Vous êtes sur la page 1sur 33

var data={"specialtyName":"Authors and Editors in Nephrology and

Hypertension","contributorTypes":[{"name":"Editors-in-Chief","contributors":
[{"name":"George L Bakris, MD","credentials":["Editor-in-Chief — Nephrology
\n","Section Editor — Hypertension\n","Professor of Medicine\n","The University of
Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer; Boehringer
Ingelheim; Relypsa; Vascular Dynamics [Diabetic neuropathy, diabetes, hypertension
(Empagliflozin, patiromer)]. Consultant/Advisory Boards: AstraZeneca; Bayer;
Boehringer Ingelheim; Relypsa; Vascular Dynamics; Merck [Nephropathy, diabetes,
hypertension (Empagliflozin, Patiromer); Pfizer; NxStage [Diabetic neuropathy,
diabetes, hypertension (Empagliflozin, patiromer)]."},{"name":"Jeffrey S Berns,
MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor —
Dialysis\n","Professor of Medicine\n","Perelman School of Medicine at the
University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Amgen
[Clinical Trial EC (Darbepoetin)]."},{"name":"Daniel C Brennan, MD,
FACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Renal
Transplantation\n","Professor of Medicine\n","Medical Director and Co-Director of
the Comprehensive Transplant Center, Department of Internal Medicine, Division of
Nephrology\n","Johns Hopkins Medical School"],"disclosure":"Grant/Research/Clinical
Trial Support: Alexion; CareDx; Oxford Immunotech; Veloxis [Atypical hemolytic
uremic syndrome, antibody mediated rejection, delayed graft function,
immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab,
mycophenolate, antithymocyte globulin)]. Speaker's Bureau: Alexion; Sanofi;
Novartis; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection,
long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus,
belatacept, rituximab, mycophenolate, valganciclovir, antithymocyte globulin)].
Consultant/Advisory Boards: Alexion; Sanofi; Veloxis [Atypical hemolytic uremic
syndrome, antibody mediated rejection, long-term outcomes, immunosuppression,
induction (Eculizumab, tacrolimus, antithymocyte globulin)]."},{"name":"Michael
Emmett, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor —
Fluid and Electrolytes\n","Chief of Internal Medicine\n","Baylor University Medical
Center"],"disclosure":"Consultant/Advisory Boards: ZS Pharma [Treatment of
hyperkalemia (Potassium binder, zirconium silicate)]."},{"name":"Richard J
Glassock, MD, MACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor
— Glomerular Diseases\n","Emeritus Professor\n","The David Geffen School of
Medicine at UCLA"],"disclosure":"Speaker's Bureau: Genentech [Vasculitis
(Rituximab)]. Consultant/Advisory Boards: Bristol-Myers-Squibb [Lupus nephritis,
FSGS (Abatacept)]; ChemoCentryx [Vasculitis, diabetes (Acocapan)]; Retrophin
[FSGS(Sparsentan)]. Equity Ownership/Stock Options: Reata (Bardoxolone)."},
{"name":"Stanley Goldfarb, MD","credentials":["Editor-in-Chief —
Nephrology\n","Section Editor — Mineral and Bone Metabolism; Renal Ureteral
Stones\n","Professor of Medicine\n","University of Pennsylvania School of
Medicine"],"disclosure":""},{"name":"Norman M Kaplan, MD","credentials":["Editor-
in-Chief — Nephrology \n","Section Editor — Hypertension\n","Clinical Professor of
Internal Medicine\n","University of Texas Southwestern Medical
Center"],"disclosure":""},{"name":"Steve J Schwab, MD","credentials":["Editor-in-
Chief — Nephrology\n","Section Editor — Dialysis\n","Chancellor\n","University of
Tennessee Health Science Center"],"disclosure":""},{"name":"Richard H Sterns,
MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and
Electrolytes\n","Professor Emeritus\n","University of Rochester School of Medicine
and Dentistry"],"disclosure":""}]},{"name":"Deputy Editors","contributors":
[{"name":"John P Forman, MD, MSc","credentials":["Senior Deputy Editor —
UpToDate\n","Deputy Editor — Nephrology\n","Assistant Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Albert Q Lam,
MD","credentials":["Deputy Editor — Nephrology\n","Assistant Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Alice M Sheridan,
MD","credentials":["Deputy Editor — Nephrology\n","Assistant Professor of
Medicine\n","Harvard Medical School"],"disclosure":""}]},{"name":"Section
Editors","contributors":[{"name":"Gerald B Appel, MD","credentials":["Section
Editor — Glomerular Diseases\n","Professor of Medicine\n","Columbia University
College of Physicians and Surgeons"],"disclosure":"Grant/Research/Clinical Trial
Support: Regulus Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-
Myers Squibb [Focal Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3
Glomerulopathies (ACH-0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy
(Atacicept)]; Reatta [Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental
Glomerulosclerosis (Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)];
Chemocentryx [Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)].
Speaker's Bureau: Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects
(Alemtuzumab)]. Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals;
Bristol-Myers Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer;
Genzyme-Sanofi; Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx
[Immunosuppressives (Drugs under development for immunosuppression)]."},
{"name":"George L Bakris, MD","credentials":["Editor-in-Chief — Nephrology
\n","Section Editor — Hypertension\n","Professor of Medicine\n","The University of
Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer; Boehringer
Ingelheim; Relypsa; Vascular Dynamics [Diabetic neuropathy, diabetes, hypertension
(Empagliflozin, patiromer)]. Consultant/Advisory Boards: AstraZeneca; Bayer;
Boehringer Ingelheim; Relypsa; Vascular Dynamics; Merck [Nephropathy, diabetes,
hypertension (Empagliflozin, Patiromer); Pfizer; NxStage [Diabetic neuropathy,
diabetes, hypertension (Empagliflozin, patiromer)]."},{"name":"Jeffrey S Berns,
MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor —
Dialysis\n","Professor of Medicine\n","Perelman School of Medicine at the
University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Amgen
[Clinical Trial EC (Darbepoetin)]."},{"name":"Daniel C Brennan, MD,
FACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Renal
Transplantation\n","Professor of Medicine\n","Medical Director and Co-Director of
the Comprehensive Transplant Center, Department of Internal Medicine, Division of
Nephrology\n","Johns Hopkins Medical School"],"disclosure":"Grant/Research/Clinical
Trial Support: Alexion; CareDx; Oxford Immunotech; Veloxis [Atypical hemolytic
uremic syndrome, antibody mediated rejection, delayed graft function,
immunosuppression, induction (Eculizumab, tacrolimus, belatacept, rituximab,
mycophenolate, antithymocyte globulin)]. Speaker's Bureau: Alexion; Sanofi;
Novartis; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection,
long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus,
belatacept, rituximab, mycophenolate, valganciclovir, antithymocyte globulin)].
Consultant/Advisory Boards: Alexion; Sanofi; Veloxis [Atypical hemolytic uremic
syndrome, antibody mediated rejection, long-term outcomes, immunosuppression,
induction (Eculizumab, tacrolimus, antithymocyte globulin)]."},{"name":"John M
Burkart, MD","credentials":["Section Editor — Dialysis\n","Professor of
Medicine/Nephrology\n","Wake Forest University Medical
Center"],"disclosure":"Employment: Health Systems Management."},{"name":"Gary C
Curhan, MD, ScD","credentials":["Section Editor — Chronic Kidney
Disease\n","Editor-in-Chief Emeritus\n","Clinical Journal of the American Society
of Nephrology\n","Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Allena
Pharmaceuticals [Oxalate]. Consultant/Advisory Boards: Allena Pharmaceuticals
[Oxalate, nephrolithiasis]; Decibel Therapeutics (Hearing loss/tinnitus); Shire
[hypoparathyroidism]; RenalGuard [Acute kidney injury]. Consultant/Advisory Boards
(spouse/partner): Decibel Therapeutics (Hearing loss, tinnitus)]. Equity
Ownership/Stock Options: Allena Pharmaceuticals. Other Financial Interest: American
Society of Nephrology [CJASN Editor-in-Chief]."},{"name":"Michael Emmett,
MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and
Electrolytes\n","Chief of Internal Medicine\n","Baylor University Medical
Center"],"disclosure":"Consultant/Advisory Boards: ZS Pharma [Treatment of
hyperkalemia (Potassium binder, zirconium silicate)]."},{"name":"Fernando C
Fervenza, MD, PhD","credentials":["Section Editor — Glomerular Diseases
\n","Professor of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial support: Genentech
[Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA nephropathy]
and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical [Monoclonal protein-
mediated renal diseases (Daratumumab)]. Consultant/Advisory Boards: Alexion
pharmaceutical [complement-mediated diseases]; Visterra pharmaceutical [complement-
mediated diseases]. Employment: Mayo Clinic."},{"name":"Richard J Glassock, MD,
MACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor — Glomerular
Diseases\n","Emeritus Professor\n","The David Geffen School of Medicine at
UCLA"],"disclosure":"Speaker's Bureau: Genentech [Vasculitis (Rituximab)].
Consultant/Advisory Boards: Bristol-Myers-Squibb [Lupus nephritis, FSGS
(Abatacept)]; ChemoCentryx [Vasculitis, diabetes (Acocapan)]; Retrophin
[FSGS(Sparsentan)]. Equity Ownership/Stock Options: Reata (Bardoxolone)."},
{"name":"Stanley Goldfarb, MD","credentials":["Editor-in-Chief
— Nephrology\n","Section Editor — Mineral and Bone Metabolism; Renal Ureteral
Stones\n","Professor of Medicine\n","University of Pennsylvania School of
Medicine"],"disclosure":""},{"name":"Thomas A Golper, MD","credentials":["Section
Editor — Dialysis\n","Professor of Medicine\n","Vanderbilt University Medical
Center"],"disclosure":"Consultant/Advisory Board: Keryx [Peritoneal dialysis
(Ferric citrate)]."},{"name":"Lee A Hebert, MD","credentials":["Section Editor —
Glomerular Diseases \n","Professor of Medicine\n","Ohio State University
\n","Wexner College of Medicine and Public
Health"],"disclosure":"Consultant/Advisory Boards: Best Doctors in America
[Glomerular diseases]; ARDEA [Uricosuric drug]; Alexion [Eculizumab]."},
{"name":"Norman M Kaplan, MD","credentials":["Editor-in-Chief — Nephrology
\n","Section Editor — Hypertension\n","Clinical Professor of Internal
Medicine\n","University of Texas Southwestern Medical Center"],"disclosure":""},
{"name":"Jonathan B Kruskal, MD, PhD","credentials":["Section Editor — Kidney
Disease\n","Professor of Radiology\n","Harvard Medical School"],"disclosure":""},
{"name":"Christophe Legendre, MD","credentials":["Section Editor — Renal
Transplantation\n","Professor of Nephrology\n","Université Paris Descartes\n","Head
of the Adult Nephrology and Transplantation Unit\n","Hôpital
Necker"],"disclosure":"Speaker's Bureau: Alexion, Novartis [Transplantation
(Everolimus, Eculizumab). Consultant/Advisory Boards: Alexion [Transplantation
(Eculizumab)]."},{"name":"Barbara Murphy, MB, BAO, BCh, FRCPI","credentials":
["Section Editor — Renal Transplantation\n","Professor of Medicine\n","Mount Sinai
School of Medicine"],"disclosure":"Consultant/Advisory Boards: Novartis [Transplant
DSMB (Anti-CD40)]; Hensa Pharmaceutical [DSMB]."},{"name":"Paul M Palevsky,
MD","credentials":["Section Editor — Renal Failure\n","Professor of
Medicine\n","University of Pittsburgh\n","VA Pittsburgh Healthcare
System"],"disclosure":"Grant/Research/Clinical Trial Support: Spectral Medical
[Sepsis (Endotoxin assay)]. Consultant/Advisory Boards: Baxter [Dialysis
(Hemodialysis equipment, peritoneal dialysis equipment and supplies, continuous
renal replacement therapy equipment and solutions)]; Durect [Potential agent for
AKI]; HealthSpan Dx [Novel diagnostic test for prediction of AKI]; GE Healthcare
[Radiocontrast agents and equipment]."},{"name":"Ronald D Perrone,
MD","credentials":["Section Editor — Cystic Disease\n","Professor of
Medicine\n","Tufts University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [Polycystic
kidney disease (Tolvaptan)]; Kadmon [Polycystic kidney disease (Tesevatinib)];
Department of Defense [Polycystic kidney disease (Metformin)]. Consultant/Advisory
Boards: Otsuka [Polycystic kidney disease (Tolvaptan)]; Novartis [Polycystic kidney
disease]; Misubishi Tanabe [Polycystic kidney disease]; Sanofi-Genzyme [Polycystic
kidney disease]."},{"name":"Glenn M Preminger, MD","credentials":["Section Editor —
Renal Ureteral Stones\n","Professor of Urologic Surgery\n","Duke University Medical
Center\n","Director of Education\n","Endourological
Society"],"disclosure":"Consultant/Advisory Boards: Retrophin [Cystine stones
(Tiopronin)]; Boston Scientific [Surgical stone management (Endourology
equipment)]."},{"name":"L Darryl Quarles, MD","credentials":["Section Editor —
Renal Osteodystrophy\n","Director, Division of Nephrology\n","Associate Dean for
Research\n","The University of Tennessee Health Science
Center"],"disclosure":"Speaker's Bureau: Amgen [Calcimimetic (Cinacalcet)]."},
{"name":"Brad H Rovin, MD","credentials":["Section Editor — Glomerular Diseases
\n","Professor of Medicine and Pathology\n","The Ohio State University College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Glomerular
Diseases/Molecular Interrogation of Kidney Biopsies, Precision
Medicine/Biomarkers]. Consultant/Advisory Boards: Alexion [Lupus Nephritis
(Eucluzimab)]; Aurinia [Lupus Nephritis, FSGS (Voclosporin)]; Biogen Idec [Lupus
Nephritis (Anti-TWEAK)]; Biomarin [Hereditary Disorders of Metabolic Disorders
(Pegvaliase)]; Bristol Myers Squibb [FSGS, MCD (Abatacept)]; Chemocentryx [Lupus
Nephritis, ANCA Vasculitis, C3 Glomerulopathy (Avacopan)]; EMD Serono [IgA
Nephropathy (Atacicept)]; Frazier Life Sciences [Lupus Nephritis]; Genentech [Lupus
Nephritis, ANCA Vasculitis (Rituximab, Obinutuzumab)]; Lupus Foundation of America
[Lupus Nephritis]; Mallinkrodt [Lupus Nephritis, FSGS (ACTHAR Gel)]; Medimmune
[Lupus Nephritis (Anti-interferon)]; Novartis [IgA Nephropathy (Factor B
Inhibitor)]; Pharmalink [IgA Nephropathy]; Retrophin [IgA Nephropathy
(Sparsenten)]; Rigel [IgA Nephropathy (Fostamatinib])."},{"name":"Steve J Schwab,
MD","credentials":["Editor-in-Chief — Nephrology\n","Section Editor —
Dialysis\n","Chancellor\n","University of Tennessee Health Science
Center"],"disclosure":""},{"name":"Richard H Sterns, MD","credentials":["Editor-in-
Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Professor
Emeritus\n","University of Rochester School of Medicine and
Dentistry"],"disclosure":""},{"name":"William B White, MD","credentials":["Section
Editor — Hypertension\n","Professor of Medicine\n","Chief, Hypertension and
Clinical Pharmacology\n","Calhoun Cardiology Center \n","University of Connecticut
School of Medicine, Farmington\n","Past President\n","American Society of
Hypertension 2012-2014\n","Editor-in-Chief\n","Blood Pressure
Monitoring"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Vascular
medicine]. Consultant/Advisory Boards: Data Safety Monitoring Boards: Teva
[Multiple sclerosis (Laquinimod)]; Lundbeck [Hypotension (Droxidopa)]; Steering
Committees: Takeda [Diabetes (Alogliptin)], Relypsa [Hyperkalemia (Patiromer)];
Cardiovascular End Point Committees: Takeda [Gout (Febuxostat)]; Forest [COPD
(Roflumilast and Aclidinium)]; Roche [Anemia (Mircera)]; AstraZeneca [COPD]."}]},
{"name":"Editorial Assistants","contributors":[{"name":"Megan McLaurin, BA,
BS","credentials":["Editorial Assistant ─ UpToDate"],"disclosure":""},
{"name":"Rebecca Mueller, BA","credentials":["Senior Editorial Assistant —
UpToDate"],"disclosure":""},{"name":"Elizabeth Packer, MA","credentials":
["Development Editor — UpToDate"],"disclosure":""}]},
{"name":"Authors","contributors":[{"name":"Behdad Afzali, MRCP, PhD, PGDip, FHEA,
MAcadMEd","credentials":["Wellcome Trust Intermediate Research Fellow\n","King's
College Honorary Consultant Nephrologist\n","Guy's and St Thomas's Hospitals, NHS
Trust, UK\n","Guest Researcher, National Institutes of Health,
USA"],"disclosure":""},{"name":"Rajiv Agarwal, MD","credentials":["Professor of
Medicine\n","Indiana University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Janssen; Bayer [Blood pressure
(Blood pressure medications)]."},{"name":"Nada Alachkar, MD","credentials":
["Associate Professor of Medicine, Division of Nephrology\n","The Johns Hopkins
University School of Medicine"],"disclosure":""},{"name":"Muhammad Alam, MD,
MPH","credentials":["Staff Nephrologist\n","Kidney Care Center, Little Rock,
AR"],"disclosure":""},{"name":"Barbara D Alexander, MD, MHS","credentials":
["Professor of Medicine and Pathology \n","Duke University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [Fungal
disease (Isavuaconazole, micafungin, liposomal amphotericin B)]; Synexis [Fungal
disease (New antifungal agent)]; Viamet [Fungal disease (New antifungal agent)];
Gilead [Respiratory syncytial virus]; Shire [Cytomegalovirus infection
(Mirabivir)]. Consultant/Advisory Boards: Shire [Cytomegalovirus infection
(Mirabivir)]; Astellas [Fungal infections (Isavuconazole)]; Cidara [Fungal
infections (New antifungal agent)]; Scynexis [Fungal disease (New antifungal
agent)]; Lediant [Fungal disease (Amphotericin B lipid complex)]."},{"name":"Tarek
Alhamad, MD, MS, FACP, FASN","credentials":["Assistant Professor of
Medicine\n","Washington University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Mallinckrodt
[Nephrotic syndrome (ACTH gel)]; Angion [BB3 analogue]. Speaker's Bureau: Veloxis
[Immunosuppression medications (Tacrolimus XR)]. Consultant/Advisory Board: Veloxis
[Immunosuppression medications (Tacrolimus XR)]."},{"name":"Michael Allon,
MD","credentials":["Professor of Medicine\n","University of Alabama at
Birmingham"],"disclosure":"Consultant/Advisory Boards: Cormedix [Dialysis catheter
infections (nonantibiotic antimicrobial solution)]."},{"name":"Rita R Alloway,
PharmD, BCPS","credentials":["Research Professor of Medicine\n","Director,
Transplant Clinical Research\n","Director, Transplant Specialty Residency and
Fellowship\n","University of Cincinnati"],"disclosure":"Grant/Research/Clinical
Trial Support: Astellas [Renal transplantation (Tacrolimus)]; Veloxis [Renal
transplantation (Tacrolimus)]; Bristol Myers Squibb [Renal transplantation
(Belatacept)]; Novartis [Renal transplantation (Anti-CD40 ligand)]; FDA [Renal
transplantation (Generic tacrolimus products)]. Speaker's Bureau: Genzyme [Renal
transplantation (Antithymocyte globulin)]; Veloxis [Renal transplantation
(Tacrolimus extended-release tablets)]. Consultant/Advisory Boards: Genzyme [Renal
transplantation (Antithymocyte globulin)]."},{"name":"Richard F Ambinder, MD,
PhD","credentials":["James B Murphy Professor of Oncology\n","Johns Hopkins School
of Medicine"],"disclosure":"Consultant/Advisory Boards: Bristol-Myers Squibb
[Cancer drugs (Checkpoint inhibitors)]; Viracta [Cancer drugs (Therapeutic trial
for unlicensed drug)]; Cellgenesis [Cancer drugs (Imides, proteasome inhibitors)];
National Comprehensive Cancer Network [Hodgkin lymphoma, HIV malignancy)]."},
{"name":"Connie Anderson, BSN, RN, MBA","credentials":["Vice President of Clinical
Operation Northwest Kidney Centers\n","University of Washington School
of Nursing, Dean’s Advisory Committee"],"disclosure":""},{"name":"Dany Anglicheau,
MD, PhD","credentials":["Professor of Nephrology, Department of Nephrology and
Kidney Transplantation\n","Necker Hospital, APHP & Paris Descartes
University"],"disclosure":""},{"name":"Gerald B Appel, MD","credentials":["Section
Editor — Glomerular Diseases\n","Professor of Medicine\n","Columbia University
College of Physicians and Surgeons"],"disclosure":"Grant/Research/Clinical Trial
Support: Regulus Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-
Myers Squibb [Focal Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3
Glomerulopathies (ACH-0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy
(Atacicept)]; Reatta [Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental
Glomerulosclerosis (Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)];
Chemocentryx [Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)].
Speaker's Bureau: Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects
(Alemtuzumab)]. Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals;
Bristol-Myers Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer;
Genzyme-Sanofi; Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx
[Immunosuppressives (Drugs under development for immunosuppression)]."},
{"name":"Lawrence J Appel, MD, MPH","credentials":["C. David Molina Professor of
Medicine \n","Johns Hopkins University School of Medicine"],"disclosure":"Other
Financial Interest:Johns Hopkins has an institutional conflicting of interest, as
described below. “Healthways, Inc. developed the website for both interventions
used in the POWER trial in collaboration with Johns Hopkins investigators and
provided coaching effort for the transtelephonic intervention. Healthways also
provided some research funding to supplement NIH support. Under an institutional
consulting agreement with Healthways, the Johns Hopkins University received fees
for advisory services to Healthways during the POWER trial. Faculty members who
participated in the consulting services received a portion of the University fees.
On the basis of POWER trial results, Healthways developed and is commercializing a
weight-loss intervention program called Innergy. Under an agreement with
Healthways, Johns Hopkins faculty monitor the Innergy program’s content and process
(staffing, training, and counseling) and outcomes (engagement and weight loss ) to
ensure consistency with the corresponding arm of the POWER Trial. Johns Hopkins
receives fees for these services and faculty members who participate in the
consulting services receive a portion of these fees. Johns Hopkins receives royalty
on sales of the Innergy program.”"},{"name":"Andrew Arnold, MD","credentials":
["Murray-Heilig Professor of Molecular Medicine\n","University of
Connecticut"],"disclosure":""},{"name":"Robert M Arnold, MD","credentials":
["Editor-in-Chief — Palliative Care\n","Section Editor — General Principles of
Palliative Care\n","Chief, Section of Palliative Care and Medical
Ethics\n","University of Pittsburgh School of Medicine"],"disclosure":""},
{"name":"Mark D Aronson, MD","credentials":["Editor-in-Chief — Primary Care
(Adult); Hospital Medicine\n","Section Editor — General Medicine\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Akhtar Ashfaq,
MD","credentials":["Assistant Professor of Medicine\n","Albert Einstein College of
Medicine"],"disclosure":""},{"name":"Jon C Aster, MD","credentials":["Professor of
Pathology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Regeneron [Hematologic malignancies (Notch inhibitors)]; Lilly [Hematologic
malignancies (Notch inhibitors)]; Cellestia [Hematologic malignancies (Notch
inhibitors)]; Anastasis [Hematologic malignancies (Notch inhibitors)]. Equity
Ownership/Stock Options: Cellestia; Anastasis."},{"name":"Phyllis August, MD,
MPH","credentials":["Ralph A Baer, MD Professor of Research in
Medicine\n","Director, Hypertension Center\n","Division of Nephrology &
Hypertension\n","Weill Cornell Medical College"],"disclosure":""},{"name":"Seema
Baid-Agrawal, MD","credentials":["Associate Professor of Medicine\n","Sahlgrenska
Medical University, Gothenburg, Sweden"],"disclosure":""},{"name":"George L Bakris,
MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor —
Hypertension\n","Professor of Medicine\n","The University of
Chicago"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer; Boehringer
Ingelheim; Relypsa; Vascular Dynamics [Diabetic neuropathy, diabetes, hypertension
(Empagliflozin, patiromer)]. Consultant/Advisory Boards: AstraZeneca; Bayer;
Boehringer Ingelheim; Relypsa; Vascular Dynamics; Merck [Nephropathy, diabetes,
hypertension (Empagliflozin, Patiromer); Pfizer; NxStage [Diabetic neuropathy,
diabetes, hypertension (Empagliflozin, patiromer)]."},{"name":"Douglas W Ball,
MD","credentials":["Associate Professor of Medicine and Oncology\n","Johns Hopkins
University School of Medicine"],"disclosure":""},{"name":"Rasheed A Balogun,
MD","credentials":["Professor of Medicine\n","University of
Virginia"],"disclosure":""},{"name":"Steven J Bander, MD","credentials":["Associate
Professor of Medicine\n","St. Louis University\n","Medical Director, Vascular
Access Center\n","St. Luke's Hospital"],"disclosure":""},{"name":"Shweta Bansal,
MD, FASN","credentials":["Associate Professor of Medicine\n","Division of
Nephrology, UT Health Science Center at San Antonio"],"disclosure":""},
{"name":"Jonathan Barratt, PhD, FRCP","credentials":["Professor; Honorary
Consultant Nephrologist\n","University of Leicester,
UK"],"disclosure":"Consultant/Advisory Boards: Omeros [IgA nephropathy (OMS721)];
Anthera [IgAN (Blisibimob)]; EMD Serono [IgAN (Atacicept)]; Pharmalink [IgAN
(Nefecon)]; Rigel [IgAN (Fostamatnib)]."},{"name":"Rashad S Barsoum, MD, FRCP,
FRCPE","credentials":["Emeritus Professor of Medicine\n","Kasr El-Aini Medical
School, Cairo University, Egypt"],"disclosure":""},{"name":"Jan Basile,
MD","credentials":["Professor of Medicine\n","Medical University of South
Carolina\n","Ralph H Johnson Veterans Affairs Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: NHLBI [Hypertension].
Speaker's Bureau: Arbor Pharmaceuticals [Hypertension (Azilsartan)]; Janssen
[Diabetes (Canagliflozin)]. Consultant/Advisory Boards: Actavis [Hypertension
(Nebivolol)]; Amgen [Lipid-lowering (Evolocumab)]; Arbor Pharmaceuticals
[Hypertension (Azilsartan)]; Lilly [Diabetes (Dulaglutide)]; Janssen [Diabetes
(Canagliflozin)]."},{"name":"John F Beary, III, MD","credentials":["Clinical
Professor of Medicine\n","University of Cincinnati"],"disclosure":""},
{"name":"Gerald A Beathard, MD, PhD","credentials":["Clinical
Professor\n","University of Texas Medical Branch"],"disclosure":"Employment: DaVita
[Dialysis provider]- No relevant conflict on topic."},{"name":"Gillian Beauchamp,
MD","credentials":["Assistant Professor\n","University of South Florida Morsani
College of Medicine\n","Lehigh Valley Health Network Department of Emergency and
Hospital Medicine"],"disclosure":""},{"name":"Laurence H Beck, Jr, MD,
PhD","credentials":["Associate Professor of Medicine\n","Boston University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Clinical
and experimental membranous nephropathy]. Patent Holder: Boston University Medical
Center [Membranous nephropathy (Diagnostics in membranous nephropathy)]."},
{"name":"Carolyn B Becker, MD","credentials":["Associate Professor of
Medicine\n","Brigham and Women's Hospital\n","Harvard Medical
School"],"disclosure":""},{"name":"Michael A Becker, MD","credentials":["Section
Editor — Crystal Diseases\n","Professor Emeritus of Medicine\n","University of
Chicago Pritzker School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: Takeda [Urate-lowering drug safety/efficacy in gout (Febuxostat,
colchicine)]; Horizon [Urate-lowering drug safety/efficacy in gout (Pegloticase)];
Ardea Biosciences/AstraZeneca and Ironwood [Urate-lowering drug safety/efficacy in
gout (Lesinurad)]. Consultant/Advisory Boards: Takeda Pharmaceuticals [Gout drug
development (Febuxostat, colchicine)]; Horizon [Gout drug development
(Pegloticase)]; Ardea Biosciences/AstraZeneca and Ironwood [Gout drug development
(Lesinurad)]; CymaBay Therapeutics, Kowa Pharmaceuticals [Gout drug development
(Arhalofenate)]."},{"name":"Srinivasan Beddhu, MD","credentials":["Professor of
Medicine\n","University of Utah School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [Diabetic
kidney disease (Atrasentan)]; Bayer [Diabetic kidney disease (Fineronone)].
Consultant/Advisory Boards: Reata [Diabetic kidney disease]."},{"name":"Alessandro
Bellucci, MD","credentials":["Associate Professor of Medicine\n","Hofstra-North
Shore LIJ School of Medicine"],"disclosure":""},{"name":"Costantino Benedetti,
MD","credentials":["Professor of Clinical Anesthesiology\n","Ohio State
University"],"disclosure":""},{"name":"William M Bennett, MD","credentials":
["Medical Director\n","Legacy Good Samaritan Transplant
Services"],"disclosure":""},{"name":"James R Berenson, MD","credentials":["Medical
and Scientific Director\n","Institute for Myeloma and Bone Cancer
Research"],"disclosure":""},{"name":"Michael Berkoben, MD","credentials":
["Associate Professor of Medicine\n","Duke University Medical
Center"],"disclosure":""},{"name":"Bonnie L Bermas, MD","credentials":["Professor
of Medicine\n","UT Southwestern Medical Center"],"disclosure":""},{"name":"Jeffrey
S Berns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor —
Dialysis\n","Professor of Medicine\n","Perelman School of Medicine at the
University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Amgen
[Clinical Trial EC (Darbepoetin)]."},{"name":"Daniel G Bichet,
MD","credentials":["Professor of Medicine\n","Universite de
Montreal"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka
Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry (Migalastat)],
Shire [Fabry (Replagal)], Sanofi Genzyme [Fabry (Fabrazyme)]. Speaker's Bureau:
Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry
(Migalastat)], Sanofi Genzyme [Fabry (Fabrazyme)]. Consultant/Advisory Boards:
Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry
(Migalastat)], Sanofi Genzyme [Fabry (Fabrazyme)]."},{"name":"John D Bisognano, MD,
PhD","credentials":["Professor of Medicine, Cardiology\n","University of Rochester
Medical Center"],"disclosure":""},{"name":"Robert M Black, MD","credentials":
["Professor of Clinical Medicine\n","University of Massachusetts Medical
Center"],"disclosure":""},{"name":"James H Black, III, MD","credentials":
["Associate Professor of Surgery\n","Johns Hopkins University"],"disclosure":""},
{"name":"Christopher R Blagg, MD, FRCP","credentials":["Professor Emeritus of
Medicine\n","University of Washington"],"disclosure":""},{"name":"Peter J
Blankestijn, MD","credentials":["Associate Professor in Nephrology\n","University
Medical Center, Utrecht, The Netherlands"],"disclosure":""},{"name":"Anthony
Bleyer, MD, MS","credentials":["Professor of Internal Medicine/Nephrology\n","Wake
Forest University School of Medicine"],"disclosure":""},{"name":"Michael J Bloch,
MD, FACP, FASH, FSVM, FNLA","credentials":["Associate Professor, University of
Nevada School of Medicine\n","Medical Director, Vascular Care, Renown Regional
Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca
[Diabetes (Dapagliflozin)]; Recor [Hypertension (renal denervation catheter)].
Speaker's Bureau: Jansen [Anticoagulation (Rivaroxaban)]; Amgen [Lipids
(Evolucumab)]. Consultant/Advisory Boards: Amgen [Lipids (Evolucumab)]; Takeda
[Hypertension (Azilsartan)]."},{"name":"Roy D Bloom, MD","credentials":["Professor
of Medicine\n","University of Pennsylvania"],"disclosure":"Grant/Research/Clinical
Trial Support: Veloxis Pharmaceuticals [Immunosuppression (Tacrolimus)]; Care DX
[Diagnostics (DNA blood test)]. Consultant/Advisory Boards: Abbvie [Hepatitis C
(Ombitasvir, paritaprevir, ritonavir, plus dasabuvir)]; Merck [Hepatitis C
(Elbasvir and grazoprevir)]; Care Dx [Diagnostics (DNA blood test)]."},
{"name":"Gerald S Bloomfield, MD, MPH","credentials":["Assistant Professor of
Medicine & Global Health\n","Duke University"],"disclosure":""},{"name":"John B
Bodensteiner, MD","credentials":["Senior Associate Consultant in Child and
Adolescent Neurology\n","Mayo Clinic College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Ionis (Isis) Pharmaceuticals
[SMA DSMB]; American Board of Psychiatry and Neurology [Director]."},
{"name":"Michael Bodmer, MD, MSc","credentials":["Head\n","Medical
Department\n","Zuger Kantonsspital\n","Baar, Switzerland"],"disclosure":""},
{"name":"Andrew S Bomback, MD, MPH","credentials":["Assistant Professor of
Medicine\n","Columbia University Medical Center"],"disclosure":""},{"name":"Barry A
Borlaug, MD","credentials":["Section Editor — Heart Failure\n","Professor of
Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca;
Corvia; MAST Therapeutics; Medtronic; Mesoblast; GlaxoSmithKline; Novartis [Heart
failure]. Consultant/Advisory Boards: Actelion; Amgen; Merck; AstraZeneca;
MyoKardia [Heart failure]."},{"name":"Roger Bouillon, MD, PhD, FRCP","credentials":
["Professor of Medicine\n","Katholieke Universiteit Leuven,
Belgium"],"disclosure":"Speaker's Bureau: Amgen; Chugai Pharmaceutical; Teijin;
Abiogen Pharma [Vitamin D (Vitamin D, Vitamin D analogs/metabolites)]. Patent
Holder: Hybrigenics [Vitamin D analogs (Inecalcitol)]."},{"name":"Edward W Boyer,
MD, PhD","credentials":["Director of Academic Development \n","Department of
Emergency Medicine \n","Brigham and Women's Hospital\n","Associate Professor of
Emergency Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: NIDA [Drug abuse].
Other Financial Interest: DePuy [Cobalt toxicity]."},{"name":"D Craig Brater,
MD","credentials":["Emeritus Dean, Indiana University School of Medicine\n","Vice
President for Programs, Regenstrief Foundation"],"disclosure":""},{"name":"Daniel C
Brennan, MD, FACP","credentials":["Editor-in-Chief — Nephrology\n","Section Editor
— Renal Transplantation\n","Professor of Medicine\n","Medical Director and Co-
Director of the Comprehensive Transplant Center, Department of Internal Medicine,
Division of Nephrology\n","Johns Hopkins Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Alexion; CareDx;
Oxford Immunotech; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated
rejection, delayed graft function, immunosuppression, induction (Eculizumab,
tacrolimus, belatacept, rituximab, mycophenolate, antithymocyte globulin)].
Speaker's Bureau: Alexion; Sanofi; Novartis; Veloxis [Atypical hemolytic uremic
syndrome, antibody mediated rejection, long-term outcomes, immunosuppression,
induction (Eculizumab, tacrolimus, belatacept, rituximab, mycophenolate,
valganciclovir, antithymocyte globulin)]. Consultant/Advisory Boards: Alexion;
Sanofi; Veloxis [Atypical hemolytic uremic syndrome, antibody mediated rejection,
long-term outcomes, immunosuppression, induction (Eculizumab, tacrolimus,
antithymocyte globulin)]."},{"name":"Sergey V Brodsky, MD, PhD","credentials":
["Associate Professor\n","Department of Pathology, The Ohio State
University"],"disclosure":""},{"name":"Edward M Brown, MD","credentials":
["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Patent
Holder/Royalties: NPS Pharmaceuticals [Hyperparathyroidism (Cinacalcet)]."},
{"name":"Nicholas A Buckley, MD, FRACP","credentials":["Professor of Clinical
Pharmacology\n","University of Sydney Medical School\n","Clinical
Toxicologist\n","Royal Prince Alfred Hospital"],"disclosure":""},{"name":"John M
Burkart, MD","credentials":["Section Editor — Dialysis\n","Professor of
Medicine/Nephrology\n","Wake Forest University Medical
Center"],"disclosure":"Employment: Health Systems Management."},{"name":"David L
Burns, MD","credentials":["Associate Professor of Medicine\n","Tufts University
School of Medicine"],"disclosure":""},{"name":"Michael J Burns, MD","credentials":
["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"David A Calhoun, MD","credentials":["Professor of Medicine\n","University
of Alabama at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support:
ReCore [Resistant Hypertension (Renal Nerve Denervation device)]; Medtronic
[Clinical studies of resistant hypertension (Renal Nerve Denervation device)].
Consultant/Advisory Boards: Novartis [Resistant hypertension]; Mitsubishi Tanabe
[Resistant hypertension]."},{"name":"Daniel C Cattran, MD","credentials":
["Professor of Medicine\n","University of Toronto,
Canada"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Membranous
nephropathy, FSGS (Rituximab)]; Chemocentryx [FSGS]. Consultant/Advisory Boards:
Mallinckrodt [Membranous nephropathy; focal and segmental glomerulosclerosis (ACTH
long-acting gel)]; Omerus [IgA]; Chemocentryx [Vasculitis (C3G), FSGS]."},
{"name":"Alessandro Ceschi, MD, FEAPCCT","credentials":["Medical and Scientific
Director\n","Institute of Pharmacological Sciences of Southern
Switzerland\n","Division Head of Clinical Pharmacology and Toxicology\n","Ente
Ospedaliero Cantonale, Lugano, Switzerland\n","Consultant of Clinical Pharmacology
and Toxicology\n","University Hospital Zurich, Switzerland"],"disclosure":""},
{"name":"Tak-Mao Chan, MD, FRCP","credentials":["Chair Professor & Yu Chiu Kwong
Endowed Professor in Medicine\n","University of Hong
Kong"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas
[nephrology/rheumatology/lupus nephritis (tacrolimus)]. Consultant/Advisory Boards:
Astellas [nephrology/rheumatology/lupus nephritis (tacrolimus)]; AstraZeneca
[nephology/rheumatology/lupus nephritis (a biologic in Phase 2 program)]; Novartis
[nephology/rheumatology/lupus nephritis (a biologic in Phase 2/3 program]."},
{"name":"Anil Chandraker, MD, FASN, FRCP","credentials":["Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Shire [Antibody-mediated rejection (Eculizumab)]. Consultant/Advisory
Boards: T2 Biosystems; Dompé; Veloxis [Immunosuppression (Tacrolimus)]."},
{"name":"Arlene B Chapman, MD","credentials":["Professor of Medicine\n","University
of Chicago Pritzker School of Medicine"],"disclosure":""},{"name":"Julia F Charles,
MD, PhD","credentials":["Associate Physician\n","Brigham and Women's
Hospital\n","Assistant Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards (Spouse): Veracyte. Equity
Ownership/Stock Options (Spouse): Metera Pharmaceuticals; Numera Biosciences."},
{"name":"Horng H Chen, MD","credentials":["Professor of Medicine\n","Mayo Medical
School"],"disclosure":""},{"name":"Alfred K Cheung, MD","credentials":["Professor
of Internal Medicine\n","University of Utah School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Baxter [DSMB for dialysis
trial (Dialysis machines and supplies)]; Boehringer Ingelheim [DSMB
(Empagliflozin)]. Equity Ownership/Stock Options: Merck."},{"name":"Chee Kay
Cheung, PhD, MRCP","credentials":["Clinical Lecturer\n","University of Leicester,
UK"],"disclosure":""},{"name":"Arkadi A Chines, MD","credentials":["Clinical
Professor of Medicine\n","University of California, Los Angeles"],"disclosure":""},
{"name":"Monique E Cho, MD","credentials":["Division of Nephrology and
Hypertension\n","University of Utah School of Medicine"],"disclosure":""},
{"name":"W James Chon, MD, FACP, FASN, FAST","credentials":["Associate
Professor\n","University of Missouri-Kansas City (UMKC) School of
Medicine\n","Medical Director, Renal Transplant Program\n","St. Luke's Health
System"],"disclosure":""},{"name":"Tushar A Chopra, MD","credentials":["Assistant
Professor Of Medicine\n","University of Virginia Health System"],"disclosure":""},
{"name":"Gabriel Choukroun, MD, PhD","credentials":["Head of Nephrology, Dialysis,
Transplantation Department\n","CHU Amiens and Picardie
University"],"disclosure":"Consultant/Advisory Boards: VIFOR [Iron therapy
(Ferrinject) and Hyperphosphatemia (Velforo)]; AMGEN [Hyperparathyroidism
(Etelcalcetide)]"},{"name":"Megan B Clowse, MD, MPH","credentials":["Assistant
Professor of Medicine\n","Duke University Medical Center\n","Division of
Rheumatology and Immunology"],"disclosure":""},{"name":"Adi Cohen, MD,
MHS","credentials":["Associate Professor of Medicine\n","Columbia University
Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen
[Osteoporosis (Denosumab)]; Eli Lilly [Osteoporosis (Teriparatide)].
Consultant/Advisory Boards (Spouse): Annapurna Pharmaceuticals [Cardiology (No
relevant product)]."},{"name":"Wilson S Colucci, MD","credentials":["Section Editor
— Heart Failure\n","Professor of Medicine\n","Boston University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Novartis [Heart failure
(Valsartan, sacubitril/valsartan)], Merck [Heart failure (Enalapril)], Amgen [Heart
failure (Ivabradine)]."},{"name":"Michael J Connor, Jr, MD","credentials":
["Assistant Professor - Critical Care Medicine & Nephrology\n","Emory University
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Baxter
[CRRT (On site PI)."},{"name":"Robin Conwit, MD","credentials":["Program Director,
Division of Extramural Research\n","National Institutes of Health, National
Institute of Neurological Disorders and Stroke"],"disclosure":""},{"name":"Mary
Corretti, MD, FACC","credentials":["Associate Professor of Medicine\n","Johns
Hopkins Hospital School of Medicine"],"disclosure":""},{"name":"Steven Coutre,
MD","credentials":["Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Gary M Cox, MD","credentials":["Professor of
Medicine\n","Duke University Medical Center"],"disclosure":""},{"name":"Daniel W
Coyne, MD","credentials":["Professor of Medicine\n","Washington University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Janssen
[Diabetes (Canigloflozin)]; Fibrogen [Anemia (Investigational)]; GSK [Anemia
(Investigational)]; ZS Pharma [Hyperkalemia (Investigational)]; Clegene [Anemia
(Investigational)]; Eli Lily [Anemia (Investigational)]; Medibeacon [GFR
measurement (Investigational)]. Speaker's Bureau: Fresenius Medical Care Group
[Phosphate binder (Sucroferric oxyhydroxide)]. Consultant/Advisory Boards:
Fresenius [Phosphate binder (Sucroferric oxyhydroxide)]; Vifor [IV irons (Ferric
carboxymaltose)]; Eli Lilly [Anemia (Investigational)]; Medibeacon [GFR measurement
(Investigational)]; GSK [Anemia (Investigational)]; AMAG [IV irons (Ferumoxytol)];
AstraZeneca [Anemia (Investigational)]."},{"name":"Adam Cuker, MD,
MS","credentials":["Assistant Professor of Medicine, Assistant Professor of
Pathology & Laboratory Medicine\n","Perelman School of Medicine University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Biogen-Idec,
Spark Therapeutics, T2 Biosystems, Shire Pharmaceuticals. Consultant/Advisory
Boards: Biogen-Idec, Diagnostica Stago."},{"name":"Rochelle Cunningham,
MD","credentials":["Staff Physician\n","Park West Medical Center, Baltimore,
MD"],"disclosure":""},{"name":"Gary C Curhan, MD, ScD","credentials":["Section
Editor — Chronic Kidney Disease\n","Editor-in-Chief Emeritus\n","Clinical Journal
of the American Society of Nephrology\n","Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Allena
Pharmaceuticals [Oxalate]. Consultant/Advisory Boards: Allena Pharmaceuticals
[Oxalate, nephrolithiasis]; Decibel Therapeutics (Hearing loss/tinnitus); Shire
[hypoparathyroidism]; RenalGuard [Acute kidney injury]. Consultant/Advisory Boards
(spouse/partner): Decibel Therapeutics (Hearing loss, tinnitus)]. Equity
Ownership/Stock Options: Allena Pharmaceuticals. Other Financial Interest: American
Society of Nephrology [CJASN Editor-in-Chief]."},{"name":"Vivette D D'Agati,
MD","credentials":["Professor of Pathology\n","Columbia University\n","College of
Physicians and Surgeons"],"disclosure":""},{"name":"Maria Dall'Era,
MD","credentials":["Professor of Medicine\n","University of California, San
Francisco"],"disclosure":"Consultant/Advisory Boards: Genentech [Lupus
(Rituximab)]."},{"name":"Gabriel Danovitch, MD","credentials":["Distinguished
Professor of Medicine\n","University of California, Los Angeles"],"disclosure":""},
{"name":"Andrew Davenport, MD, FRCP","credentials":["Director of Dialysis
Research\n","UCL Centre for Nephrology\n","University College
London"],"disclosure":""},{"name":"Kathryn A Davis, MD, MSTR","credentials":
["Assistant Professor of Neurology\n","University of
Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Lundbeck [Epilepsy
(Clobazam)]."},{"name":"Sara N Davison, MD, MHSc, FRCP(C)","credentials":
["Professor of Medicine\n","University of Alberta"],"disclosure":""},
{"name":"Buddhadeb Dawn, MD","credentials":["Maureen and Marvin Dunn
Professor\n","University of Kansas Medical Center"],"disclosure":""},{"name":"Bess
Dawson-Hughes, MD","credentials":["Senior Scientist and Director\n","Bone
Metabolism Laboratory\n","Tufts University"],"disclosure":"Grant/Research/Clinical
Trial Support: Pfizer [Vitamin D (Caltrate with vitamin D)]; DSM [Vitamin D
(vitamin D)]. Consultant/Advisory Boards: Pfizer [Calcium, general nutrition
[Calcium and vitamin D supplement]); Nestle [Nutrition in older adults (Supplement
drinks)]; Takeda [Calcium (Calcium supplement)]."},{"name":"Marc E De Broe, MD,
PhD","credentials":["Emeritus Professor of Medicine\n","University of Antwerp,
Belgium"],"disclosure":""},{"name":"Brian S Decker, MD, PharmD","credentials":
["Assistant Professor of Clinical Medicine\n","Indiana University Department of
Medicine"],"disclosure":""},{"name":"Christopher deFilippi, MD,
FACC","credentials":["Vice Chair of Academic Affairs\n","Inova Heart and Vascular
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Roche Diagnostics
[Chronic disease risk stratification (Troponin T, NT-proBNP)]. Consultant/Advisory
Boards: Roche Diagnostics [Chronic disease risk stratification (Troponin T)];
Siemens Healthcare Diagnostics [Chronic disease risk stratification (Troponin I)];
Thermo Fisher [Dypnea evaluation (Procalcitonin)]; Ortho Diagnostics [Acute MI
diagnosis, acute heart failure diagnosis (Troponin I, NT-proBNP)]; Radiometer
[Acute MI diagnosis (Troponin I)]; Metabolomics [Metabolomes (Chronic disease risk
stratification)]; Alere [Acute heart failure diagnosis (NT-proBNP)]."},
{"name":"Rowena Delos Santos, MD","credentials":["Assistant Professor of
Medicine\n","Washington University in St.
Louis"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Diabetes
(Sitagliptan)]. Equity Ownership/Stock Options (spouse/partner): Pfizer."},
{"name":"Michael A DeVita, MD","credentials":["Director of Critical Care
Medicine\n","Harlem Hospital Center"],"disclosure":""},{"name":"Kathryn Diemer,
MD","credentials":["Associate Professor, Clinical Director, Bone Health
Program\n","Division of Bone and Mineral Diseases, Washington University School of
Medicine"],"disclosure":"Speaker’s Bureau: Amgen [Osteoporosis (Denosumab)]."},
{"name":"Jodie Dionne-Odom, MD","credentials":["Assistant Professor of
Medicine\n","Division of Infectious Diseases\n","University of Alabama at
Birmingham"],"disclosure":""},{"name":"Angela Dispenzieri, MD","credentials":
["Serene M. and Frances C. Durling Professor of Medicine and of Laboratory
Medicine, and Pathology\n","Mayo Clinic"],"disclosure":"Grant/Research/Clinical
Trial Support: Pfizer, Celgene, Takeda, Alnylam, Janssen, Prothena (tafamidis,
lenalidomide, pomalidomide, ixazomib, bortezomib, NEOD001]."},{"name":"Arjang
Djamali, MD, MS, FASN","credentials":["Professor of Medicine and Surgery\n","Head
of Nephrology Division\n","Department of Medicine\n","University of Wisconsin
School of Medicine and Public Health"],"disclosure":"Grant/Research/Clinical Trial
Support: Bristol-Myers Squibb, Takeda-Millennium [Rejection (Belatacept,
Ixazomib)]."},{"name":"Pamela S Douglas, MD","credentials":["Ursula Geller
Professor of Research in Cardiovascular Diseases\n","Duke University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: National Institutes
of Health (NIH) – NHLBI, NCI, NIAID; Columbia University [Diagnostic testing];
Massachusetts General Hospital [Prevention]; Memorial Sloan Kettering Cancer Center
[cancer]; City of Hope [cancer]; Bristol Meyers Squibb [Hepatitis C]; GE HealthCare
[Diagnostic testing (Optison)]; Gilead [Hepatitis C (Sofosbuvir)]; HeartFlow [CAD
diagnosis (FFRCT)]; Singulex; Abbott [biomarkers]; Kowa [prevention]; Verily
[genomics]. Grant/Research/Clinical Trial Support (Spouse): National Institutes of
Health (NIH) – NHGRI, NIGMS; DARPA; USAMRIID; Abbott; Novartis; Merck; Singulex; US
Defense Advanced Research Projects Agency; United States Air Force; Henry Jackson
Foundation; Abbott; 23andMe. Consultant/Advisory Boards: Patient Advocate
Foundation; General Electric Healthcare DSMB [Heart failure (AdreScan)]; TIMI DSMB
[anorexigen]. Consultant/Advisory Boards (Spouse): Alere, Inc; Genome Magazine;
CardioDx; Pappas Ventures. Equity Ownership/Stock Options (Spouse): CardioDX;
Fabric Genomics; Alere, Inc; Origin Commercial Advisors, LLC; Host Response."},
{"name":"Matthew T Drake, MD, PhD","credentials":["Associate Professor of
Medicine\n","Mayo Clinic"],"disclosure":""},{"name":"Richard
H Drew, PharmD, MS, FCCP, FIDP","credentials":["Professor, Campbell University
College of Pharmacy and Health Sciences\n","Associate Professor and Clinical
Pharmacist, Infectious Diseases\n","Duke University Medical
Center"],"disclosure":"Speaker's Bureau: American Society of Microbiology, Campbell
University [Accredited CE programs on various antibiotics, antibiotic stewardship].
Consultant/Advisory Boards: Cidara [Antifungals]. Equity Ownership/Stock Options:
CustomID Clinical Decision Support [Equity owner, all antibiotics]."},{"name":"Marc
K Drezner, MD","credentials":["Section Editor — Bone Disease\n","Professor of
Medicine\n","University of Wisconsin Medical School"],"disclosure":""},
{"name":"Brent M Egan, MD","credentials":["Professor of Medicine\n","University of
South Carolina School of Medicine-Greenville\n","Chief Science Officer, Care
Coordination Institute"],"disclosure":"Grant/Research/Clinical Trial Support:
Boehringer [Diabetes (Empagliflozin)]. Speaker's Bureau: Medtronic [Hypertension
(Renal artery denervation to lower blood pressure)]; Merck-Sorono [Hypertension,
heart failure (Bisoprolol)]; Emcure (clinical epidemiology, pathophysiology,
treatment of hypertension). Consultant/Advisory Boards: Valencia [Hypertension
(Device-based treatment to lower blood pressure)]; Inside Edge Consulting [Clinical
trials (Patient recruitment and retention)]."},{"name":"Georg B Ehret,
MD","credentials":["Division of Cardiology\n","Geneva University Hospitals,
Switzerland\n","McKusick Institute of Genetic Medicine\n","Johns Hopkins
University"],"disclosure":"Consultant/Advisory Boards: Servier Laboratories
[Hypertension (Perindopril, amlodipine, indapamide)]; Amgen [Dyslipidemia
(Evolocumab)]; Boehringer [Diabetes and hypertension (Empagliflozin)."},
{"name":"John F Eidt, MD","credentials":["Section Editor — Vascular and
Endovascular Surgery\n","Professor of Surgery, Texas A&M Health Science
Center\n","Vice Chair of Vascular Surgical Services, Baylor Heart and Vascular
Hospital at Dallas"],"disclosure":""},{"name":"Ghada El-Hajj Fuleihan, MD,
MPH","credentials":["Professor of Medicine\n","American University of Beirut
Medical Center, Lebanon"],"disclosure":""},{"name":"Carl-Gustaf Elinder, MD,
PhD","credentials":["Professor and Senior Consultant of Renal
Medicine\n","Karolinska Institute, Sweden"],"disclosure":""},{"name":"William J
Elliott, MD, PhD","credentials":["Section Editor — Hypertension\n","Professor of
Preventive Medicine, Internal Medicine and Pharmacology\n","Head, Division of
Pharmacology\n","Chair, Department of Biomedical Sciences\n","Pacific Northwest
University of Health Sciences, Yakima, WA"],"disclosure":"Other Financial Interest:
Elsevier; Springer [Hypertension (book, journal)]."},{"name":"David H Ellison, MD,
FASN, FAHA","credentials":["Professor of Medicine and Physiology &
Pharmacology\n","Oregon Health & Science University"],"disclosure":"Other Financial
Interest: Pfizer [Spoke at a sponsored conference on effect of dietary potassium on
NCC (Eplerenone)]."},{"name":"Michael Emmett, MD","credentials":["Editor-in-Chief —
Nephrology \n","Section Editor — Fluid and Electrolytes\n","Chief of Internal
Medicine\n","Baylor University Medical Center"],"disclosure":"Consultant/Advisory
Boards: ZS Pharma [Treatment of hyperkalemia (Potassium binder, zirconium
silicate)]."},{"name":"Uta Erdbruegger, MD","credentials":["Associate Professor of
Medicine\n","University of Virginia"],"disclosure":""},{"name":"Doruk Erkan, MD,
MPH","credentials":["Associate Attending Rheumatologist, Hospital for Special
Surgery\n","Associate Professor of Medicine, Weill Cornell
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Lupus Clinical
Trials Consortium; GlaxoSmithKline [Lupus (Belimumab)]; EMD Serono [lupus];
National Institutes of Health [Antiphospholipid syndrome]; Hospital for Special
Surgery Medical Education Academy [Antiphospholipid syndrome]. Consultant/Advisory
Boards: GSK (lupus); Ablynx (Antiphospholipid Syndrome)."},{"name":"Ronald J Falk,
MD","credentials":["Nan and Hugh Cullman Eminent Professor of Nephrology\n","Chair,
Department of Medicine\n","Director, UNC Kidney Center\n","University of North
Carolina-Chapel Hill"],"disclosure":""},{"name":"Pedram Fatehi, MD,
MPH","credentials":["Assistant Clinical Professor of Medicine\n","Stanford
University School of Medicine"],"disclosure":""},{"name":"Thomas Fekete,
MD","credentials":["Professor of Medicine and Microbiology\n","Temple University
School of Medicine"],"disclosure":""},{"name":"Adam S Feldman, MD,
MPH","credentials":["Assistant Professor of Surgery\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Olympus America, Inc.
[Laparoscopy, endourology (Cystoscopy equipment)]."},{"name":"Andrew Z Fenves,
MD","credentials":["Associate Professor\n","Harvard Medical School\n","Division of
Nephrology and Department of Medicine\n","Massachusetts General
Hospital"],"disclosure":""},{"name":"Fernando C Fervenza, MD, PhD","credentials":
["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Mayo Clinic
College of Medicine"],"disclosure":"Grant/Research/Clinical Trial support:
Genentech [Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA
nephropathy] and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical
[Monoclonal protein-mediated renal diseases (Daratumumab)]. Consultant/Advisory
Boards: Alexion pharmaceutical [complement-mediated diseases]; Visterra
pharmaceutical [complement-mediated diseases]. Employment: Mayo Clinic."},
{"name":"Joel S Finkelstein, MD","credentials":["Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: AbbVie [Male hypogonadism (Testosterone gel)]."},{"name":"Jay A Fishman,
MD","credentials":["Professor of Medicine\n","Harvard Medical School\n","Director,
Transplant Infectious Disease and Compromised Host Program\n","Massachusetts
General Hospital"],"disclosure":""},{"name":"Steven Flamm, MD","credentials":
["Chief, Liver Transplantation Program\n","Professor of Medicine\n","Feinberg
School of Medicine\n","Northwestern
University"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie, Gilead
(HCV). Speaker’s Bureau:\t Abbvie, Gilead, Merck (HCV). Consultant/Advisory Boards:
Abbvie, Gilead, Merck (HCV)."},{"name":"John P Forman, MD, MSc","credentials":
["Senior Deputy Editor — UpToDate\n","Deputy Editor — Nephrology\n","Assistant
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Jean
Francis, MD","credentials":["Assistant Professor of Medicine\n","Boston University
School of Medicine"],"disclosure":"Consultant/Advisory Boards: Alexion;
Mallinckrodt [Glomerular disease and aHUS]."},{"name":"Joy L Fridey,
MD","credentials":["Regional Medical Director\n","American Red Cross Blood
Services, Southern California"],"disclosure":""},{"name":"Jonathan W Friedberg,
MD","credentials":["Professor of Medicine\n","James P Wilmot Cancer Center,
University of Rochester"],"disclosure":"Consultant/Advisory Boards: Bayer [DSMB for
trials (Investigational agents)]; Astellas [DSMB for trials (Acalabrutinib)]."},
{"name":"Lawrence S Friedman, MD","credentials":["Section Editor — General
Gastroenterology\n","Professor of Medicine\n","Harvard Medical School\n","Tufts
University School of Medicine"],"disclosure":"Consultant/Advisory Boards:
Consultant, FDA (Antimicrobial Drugs Advisory Committee); Trustee, Newton-Wellesley
Hospital (through June 2017). Employment: Boston Health Care for the Homeless.
Other Financial Interest: Elsevier [Gastroenterology (Royalties from textbooks)];
McGraw-Hill [Gastroenterology (Royalties from textbooks)]; Wiley [Gastroenterology
(Royalties from textbooks)]; American Society for Gastrointestinal Endoscopy
[Gastroenterology and hepatology (Honorarium as newsletter editor)]."},
{"name":"Daniel E Furst, MD","credentials":["Section Editor — Treatment Issues in
Rheumatology\n","Clinical professor, University of Washington, Seattle\n","Clinical
professor, University of Florence, Florence, Italy\n","Professor of Rheumatology,
University of California in Los Angeles (Emeritus)\n","Director of Research,
Pacific Arthritis Associates"],"disclosure":"Grant/Research/Clinical Trial Support:
AbbVie [RA, IBD, PMS, PsA (adalimumab)]; Actelion [SSc (bosentan, macitentan)];
Amgen [RA, IBP, AS, PsA (etanercept)]; BMS [RA, SSc (abatacept)]; Corbus [SSc, SLE
(anabasum)]; NIH; Novartis; Pfizer [SSc (sildenafil)]; Roche/Genentech [RA, IBD,
AS, SSc (rituximab, tocilizumab)]. Consultant/Advisory Boards: AbbVie [RA, IBD,
PMS, PsA (adalimumab)]; Actelion [SSc (bosentan, macitentan)]; Amgen [RA, IBP, AS,
PsA (etanercept)]; BMS [RA, SSc (abatacept)]; Cytori [lab test advisory]; Novartis;
Pfizer [SSc (sildenafil)]; Roche/Genentech [RA, IBD, AS, SSc (rituximab,
tocilizumab)]."},{"name":"James N George, MD","credentials":["Professor of
Medicine\n","University of Oklahoma Health Sciences
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Ablynx [TTP
(caplacizumab)]."},{"name":"Arshia Ghaffari, DO, MA, MBA","credentials":["Assistant
Professor Clinical Medicine, Division of Nephrology\n","Keck School of Medicine,
University of Southern California"],"disclosure":"Speaker's Bureau: Baxter
Healthcare [Peritoneal dialysis (Peritoneal dialysis supplies)].
Consultant/Advisory Boards: DaVita Healthcare Partners [Dialysis services]."},
{"name":"Elsa-Grace Giardina, MD, MS, FACC, FACP, FAHA","credentials":["Professor
of Medicine\n","Director, Center for Women’s Health \n","Columbia University
Medical Center"],"disclosure":""},{"name":"C Michael Gibson, MS, MD","credentials":
["Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Bayer [Atrial
fibrillation (Rivaroxaban)]; Janssen Pharmaceuticals [Atrial fibrillation
(Rivaroxaban)]; Johnson & Johnson [Atrial
fibrillation (Rivaroxaban)]; The Medicines Company [Anticoagulation
(Bivalirudin)]; Eli Lilly and Company [Percutaneous coronary intervention
(Prasugrel)]."},{"name":"Richard J Glassock, MD, MACP","credentials":["Editor-in-
Chief — Nephrology\n","Section Editor — Glomerular Diseases\n","Emeritus
Professor\n","The David Geffen School of Medicine at UCLA"],"disclosure":"Speaker's
Bureau: Genentech [Vasculitis (Rituximab)]. Consultant/Advisory Boards: Bristol-
Myers-Squibb [Lupus nephritis, FSGS (Abatacept)]; ChemoCentryx [Vasculitis,
diabetes (Acocapan)]; Retrophin [FSGS(Sparsentan)]. Equity Ownership/Stock Options:
Reata (Bardoxolone)."},{"name":"Joel D Glickman, MD","credentials":["Professor of
Clinical Medicine\n","University of Pennsylvania School of
Medicine"],"disclosure":""},{"name":"Ary L Goldberger, MD","credentials":["Section
Editor — Electrocardiography\n","Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Other Financial Interest: Elsevier book royalties [Clinical
electrocardiography]."},{"name":"David S Goldfarb, MD, FACP, FASN","credentials":
["Professor of Medicine and Physiology\n","New York University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Allena [Nephrolithiasis
(Allena 177)]; Retrophin (Cystinuria (Tiopronin)]. Patent Holder: Ravine Group
[Nephrolithiasis, cystinuria]."},{"name":"Stanley Goldfarb, MD","credentials":
["Editor-in-Chief — Nephrology\n","Section Editor — Mineral and Bone Metabolism;
Renal Ureteral Stones\n","Professor of Medicine\n","University of Pennsylvania
School of Medicine"],"disclosure":""},{"name":"David JA Goldsmith, MA,
FRCP","credentials":["Visiting Professor\n","St. George's Hospital University
Medical School\n","GI Popescu School of Pharmacy and
Medicine"],"disclosure":"Speaker's Bureau: Amgen [CKD-MBD (Cinacalcet)]; Vifor
[CKD-MBD (Iron sucrose hydroxyoxide)]; Abbvie [CKD-MBD (Paricalcitol)]; Sanofi
[CKD-MBD (Sevelamer)]. Consultant/Advisory Board: Amgen [CKD-MBD (Cinacalcet)];
Vifor [CKD-MBD (Iron sucrose hydroxyoxide)]; Abbvie [CKD-MBD (Paricalcitol)];
Sanofi [CKD-MBD (Sevelamer)]."},{"name":"Thomas A Golper, MD","credentials":
["Section Editor — Dialysis\n","Professor of Medicine\n","Vanderbilt University
Medical Center"],"disclosure":"Consultant/Advisory Board: Keryx [Peritoneal
dialysis (Ferric citrate)]."},{"name":"David Goltzman, MD","credentials":
["Professor of Medicine\n","McGill University\n","Senior Physician, Division of
Endocrinology and Department of Medicine\n","McGill University Health
Centre"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen; Eli Lilly;
Merck [Osteoporosis]. Consultant/Advisory Boards: Amgen [Osteoporosis
(Denosumab)]."},{"name":"Peter D Gorevic, MD","credentials":["Professor of
Medicine, Rheumatology\n","Mount Sinai School of Medicine"],"disclosure":""},
{"name":"Carmen Gota, MD","credentials":["Orthopedic and Rheumatologic Institute at
Cleveland Clinic\n","Center for Vasculitis Care and Research at Cleveland
clinic"],"disclosure":""},{"name":"Stephen S Gottlieb, MD","credentials":["Section
Editor — Heart Failure\n","Professor of Medicine\n","University of Maryland School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Heart
failure (Tafamidis)]; Novartis [Heart failure (Serelaxin)]; Respicardia [Sleep
apnea (Pacing)]; Amgen [Omecamtiv mecarbil]. Consultant/Advisory Boards: BMS [Heart
failure (Natriuretic peptides)]; Cytokinetics [Heart failure (Omecamtiv
mecarbil)]."},{"name":"Saul P Greenfield, MD","credentials":["Clinical Professor of
Urology, State University of New York at Buffalo School of Medicine & Biomedical
Sciences\n","Director of Pediatric Urology, Children’s Hospital of
Buffalo"],"disclosure":""},{"name":"Muriel PC Grooteman, MD, PhD","credentials":
["Assistant Professor\n","VU University Medical Center,
Amsterdam"],"disclosure":"Speaker's Bureau: Baxter Healthcare [Hemodialysis
(Dialysis equipment)]; Fresenius Medical Care BV [Hemodialysis (Dialysis
equipment)]."},{"name":"Aditi Gupta, MD","credentials":["Assistant
Professor\n","University of Kansas Medical Center"],"disclosure":""},
{"name":"Kalpana Gupta, MD, MPH","credentials":["Professor of Medicine\n","Boston
University School of Medicine\n","Chief, Infectious Diseases\n","Boston VA
HCS"],"disclosure":"Consultant/Advisory Boards: Paratek Pharmaceuticals; Melinta
Therapeutics; Iterum Therapeutics; Tetraphase Pharmaceuticals; Ocean Spray Inc.
[UTI]."},{"name":"Laurie Gutmann, MD","credentials":["Professor and Vice Chair of
Clinical Research\n","University of Iowa"],"disclosure":"Grant/Research/Clinical
Trial Support: Alexion [Myasthenia gravis (Eculizumab)]."},{"name":"Robert G Hahn,
MD, PhD","credentials":["Professor of Anesthesiology\n","The University of
Linköping, Sweden\n","Associate Professor\n","Karolinska Institutet, Stockholm,
Sweden"],"disclosure":""},{"name":"Patrick J Hanly, MD, FRCPC, MRCPI,
DABSM","credentials":["Professor of Medicine\n","University of Calgary,
Canada"],"disclosure":"Grant/Research/Clinical Trial Support: Philips Respironics
[Sleep apnea (Continuous positive airway pressure)]. Employment: Dream Sleep
Respiratory Services [Interpretation of ambulatory sleep studies]."},{"name":"Karen
Hardinger, PharmD, BCPS","credentials":["Clinical Professor\n","University of
Missouri-Kansas City"],"disclosure":""},{"name":"Lee A Hebert, MD","credentials":
["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Ohio State
University \n","Wexner College of Medicine and Public
Health"],"disclosure":"Consultant/Advisory Boards: Best Doctors in America
[Glomerular diseases]; ARDEA [Uricosuric drug]; Alexion [Eculizumab]."},
{"name":"William L Henrich, MD, MACP","credentials":["Professor of
Medicine\n","President of the Health Science Center\n","University of Texas Health
Science Center School of Medicine"],"disclosure":""},{"name":"Charles A Herzog,
MD","credentials":["Professor of Medicine\n","Hennepin County Medical
Center/University of Minnesota"],"disclosure":"Grant/Research/Clinical Trial
Support: Amgen [Pharmaceuticals for anemia, cardiovascular disease, CKD (Epoetin,
darbepoetin, evolocumab, ivabradine)]; Peer Kidney Care Initiative [dialysis care];
Relypsa [Pharmaceuticals, hypo- and hyperkalemia (multiple drugs)]; Zoll [Sudden
cardiac death, medical devices (Wearable external cardioverter defibrillator)].
Consultant/Advisory Boards: AbbVie [Diabetes mellitus II, SONAR study
(Atrasentan)]; Fibrogen/DSMB [Pharmaceuticals, anemia (Experimental drug)]; KBP
Biosciences [Pharmaceuticals, cardiovascular disease]; OxThera [Pharmaceuticals,
experimental drug]; Relypsa [Pharmaceuticals, hyperkalemia (Patiromer)]; Sanifit
[Pharmaceuticals, mineral bone disease (experimental drug)]. Equity Ownership/Stock
Options: Boston Scientific [Medical devices (Defibrillators)]; GE [Medical devices,
echo contrast]; Merck [Pharmaceuticals]; Johnson & Johnson [Pharmaceuticals,
medical devices]."},{"name":"Tamara Hew-Butler, DPM, PhD","credentials":["Associate
Professor, Exercise Science\n","Oakland University"],"disclosure":""},
{"name":"Patricia L Hibberd, MD, PhD","credentials":["Chair, Department of Global
Health\n","Boston University School of Public Health"],"disclosure":""},
{"name":"Karl F Hilgers, MD","credentials":["Professor of Internal Medicine and
Hypertension Research\n","Friedrich-Alexander University, Erlangen-
Nuremberg\n","Vice Chair, Department of Nephrology and Hypertension\n","Erlangen
University Hospital"],"disclosure":"Grant/Research/Clinical Trial Support:
Astellas; Novartis [Kidney transplantation (Tacrolimus, sirolimus, everolimus)]."},
{"name":"Irl B Hirsch, MD","credentials":["Section Editor — Diabetes
Mellitus\n","Professor of Medicine\n","University of Washington School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic [Diabetes
(Insulin pump/sensor). Consultant/Advisory Boards: Abbott [Diabetes (Blood glucose
meters)]; Adocia [Diabetes (insulin)]; Roche [Diabetes (Blood glucose meters)];
Bigfoot Biomedical [Diabetes (Insulin pump)]."},{"name":"Nicholas Hoenich,
PhD","credentials":["Associate Member\n","Institute of Cellular Medicine, Newcastle
University"],"disclosure":""},{"name":"Jonathan Hogan, MD","credentials":
["Assistant Professor of Medicine\n","Perelman School of Medicine at the University
of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Dimerix [Glomerular
disease]; Aurinia [Glomerular disease]; Variant [Glomerular disease]."},
{"name":"Jean L Holley, MD, FACP","credentials":["Clinical Professor of
Medicine\n","University of Illinois, Urbana-Champaign"],"disclosure":""},
{"name":"Ewout J Hoorn, MD, PhD","credentials":["Professor of
Nephrology\n","Erasmus Medical Center, Rotterdam, The
Netherlands"],"disclosure":""},{"name":"Robert Hootkins, MD, PhD, FACP, FAHA,
FASN","credentials":["Clinical Associate Professor of Medicine \n","University of
Texas Southwestern"],"disclosure":"Consultant/Advisory Board: Fresenius Medical
Care [Consultant to the CMO]; Baxter Healthcare [legal consultant]; Novadiol
[(chronic kidney disease (CKD) patients with secondary hyperparathyroidism
(SHPT)]."},{"name":"Thomas M Hooton, MD","credentials":["Professor of
Medicine\n","University of Miami Miller School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Cubist [Complicated UTI
(Ceftolozane/tazobactam)]; Danone [UTI management (Hydration therapy)]; GSK
(Antimicrobial in development); Ocean Spray (Cranberry products); Paratek
Pharmaceuticals (Antimicrobial in development). Equity Ownership/Stock Options:
Fimbrion Therapeutics [UTI prevention (Development of mannosides)]."},
{"name":"William Hopkins, MD","credentials":["Associate Professor of
Medicine\n","University of Vermont College of Medicine"],"disclosure":""},
{"name":"Lesley D Hordon, MD","credentials":["Consultant in
Rheumatology\n","University of Leeds, United Kingdom"],"disclosure":""},
{"name":"Mara
J Horwitz, MD","credentials":["Assistant Professor of Medicine\n","University of
Pittsburgh"],"disclosure":""},{"name":"Chi-yuan Hsu, MD, MSc","credentials":
["Professor of Medicine\n","University of California, San
Francisco"],"disclosure":""},{"name":"Edmund Huang, MD","credentials":["Associate
Professor of Medicine\n","University of California, Los Angeles School of
Medicine\n","Cedars-Sinai Medical Center"],"disclosure":"Grant/Research/Clinical
Trial Support: CareDx [Noninvasive Diagnosis of Rejection (AlloSure)]. Other
Financial Interest: ThermoFischer [honorarium for lecture]."},{"name":"Gene G
Hunder, MD","credentials":["Section Editor — Vasculitis\n","Emeritus
Consultant\n","Professor Emeritus\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Lesley A Inker, MD, MS","credentials":
["Associate Professor of Medicine\n","Tufts University School of
Medicine"],"disclosure":""},{"name":"Olav Istre, MD, PhD","credentials":
["Professor, Deptartment of Obstetrics and Gynecology\n","South Danish
University\n","Odense, Denmark"],"disclosure":""},{"name":"Bernard G Jaar, MD, MPH,
FASN","credentials":["Assistant Professor of Medicine and
Epidemiology\n","Associate Faculty, Welch Center for Prevention, Epidemiology and
Clinical Research\n","Johns Hopkins Medical Institutions\n","Nephrology Center of
Maryland"],"disclosure":""},{"name":"Bertrand L Jaber, MD, MS, FASN","credentials":
["Professor of Medicine\n","Tufts University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Opsonix [Sepsis]."},
{"name":"Anuja Java, MD","credentials":["Instructor in Medicine\n","Washington
University School of Medicine"],"disclosure":""},{"name":"Kenar D Jhaveri,
MD","credentials":["Professor of Medicine\n","Associate Chief, Division of Kidney
Diseases and Hypertension\n","Zucker School of Medicine at
Hofstra/Northwell"],"disclosure":""},{"name":"Eric Jonasch, MD","credentials":
["Professor\n","The University of Texas MD Anderson Cancer
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Exelixis; Novartis;
Pfizer [Kidney cancer (Pazopanib, cabozantinib, sunitinib)]. Consultant/Advisory
Boards: BMS; Exelixis; Esai; Novartis; Pfizer [Kidney cancer (Nivolumab,
everolimus, pazopanib, temsirolimus, cabozantinib, sunitinib, lenvatinib)]."},
{"name":"Lynne C Jones, PhD","credentials":["Associate Professor, Orthopaedic
Surgery\n","Director, Center for Osteonecrosis Research and Education\n","Johns
Hopkins University School of Medicine"],"disclosure":""},{"name":"Harald Jüppner,
MD","credentials":["Professor of Pediatrics\n","Harvard Medical
School"],"disclosure":""},{"name":"Pradeep V Kadambi, MD, MBA, FASN,
FAST","credentials":["Professor\n","Department of Medicine\n","University of
Florida College of Medicine – Jacksonville\n","Senior Associate Dean for Clinical
Affairs\n","University of Florida College of Medicine – Jacksonville\n","President
and CEO\n","University of Florida Jacksonville Physicians,
Inc"],"disclosure":"Speaker's Bureau: Alexion [TMA (Eculizumab)].
Consultant/Advisory Boards: Alexion [TMA (Eculizumab)]."},{"name":"Kamyar Kalantar-
Zadeh, MD, MPH, PhD","credentials":["Professor & Chief, Division of Nephrology &
Hypertension \n","University of California Irvine, School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [(CKD, ESRD,
nutrition, bone and minerals (Lanthanum)]. Speaker's Bureau: Abbott; Abbvie; Amgen;
Fresenius; Otsuka; Shire [(CKD, renal nutrition, anemia, bone and minerals,
hyponatremia (Medical nutrition, paricalcitol, cinacalcet, tolvaptan, Lanthanum)].
Consultant/Advisory Boards: Baxter; Fresenius; Hospira; Kyrex; Reseverlogic;
Rockwell; Vifor [PD, CKD, anemia, acid-base, phosphorus binder, iron therapy (PD
minicaps, dialysate acid, biosimilars, new phosphorus binders, new iron
agents)]."},{"name":"Raghu Kalluri, MD, PhD","credentials":["Professor, Department
of Cancer Biology\n","Chair, Department of Cancer Biology\n","The University of
Texas MD Anderson Cancer Center"],"disclosure":""},{"name":"Nassim Kamar, MD,
PhD","credentials":["Department of Nephrology and Organ
Transplantation\n","Toulouse University Hospital, France"],"disclosure":"Other
Financial Interest (one-time lecture fees): Gilead Sciences [HCV (Sofosbuvir)]; MSD
[HCV (Grazoprevir/Elbasvir)]; Abbvie [HCV
(Ombitasvir/Paritaprévir/Ritonavir/Glecaprevir-pibrentasvir)]."},{"name":"Andre A
Kaplan, MD","credentials":["Professor of Medicine\n","University of Connecticut
Health Center"],"disclosure":"Grant/Research/Clinical Trial Support: Nipro
Corporation [Dialysis (Dialysis filters)]. Speaker's Bureau: Terumo [Plasmapheresis
(Plasmapheresis machines)]. Consultant/Advisory Boards: Vital Therapeutics
[Extracorporeal liver assist device (ELAD)]."},{"name":"Norman M Kaplan,
MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor —
Hypertension\n","Clinical Professor of Internal Medicine\n","University of Texas
Southwestern Medical Center"],"disclosure":""},{"name":"S Ananth Karumanchi,
MD","credentials":["Professor of Medicine, Obstetrics and Gynecology\n","Harvard
Medical School"],"disclosure":"Consultant/Advisory Boards: Thermofisher Scientific
[Preeclampsia (Biomarkers in preeclampsia)]. Patent Holder: Beth Israel Deaconess
Medical Center [Preeclampsia (Co-inventor on patents related to preeclampsia
biomarkers)]. Equity Ownership/Stock Options: Aggamin Therapeutics [Preeclampsia
(Novel therapies in preeclampsia)]. Other Financial Interest: Alnylam Therapeutics
[Hypertension (RNA-based therapies)]."},{"name":"Clifford E Kashtan,
MD","credentials":["Professor of Pediatrics\n","Director, Division of Pediatric
Nephrology\n","University of Minnesota Medical School\n","Executive
Director\n","Alport Syndrome Treatments and Outcomes Registry
(ASTOR)"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus Therapeutics
[Anti-microRNA therapies (Anti-microRNA-21)]; Reata Pharmaceuticals [Chronic kidney
disease (Bardoxolone)]; Novartis Institute for Biomedical Research [Urinary
biomarkers]."},{"name":"Carol A Kauffman, MD","credentials":["Editor-in-Chief —
Infectious Diseases\n","Section Editor — Fungal Infections\n","Professor of
Internal Medicine\n","University of Michigan Medical School\n","Veterans Affairs
Ann Arbor Healthcare System"],"disclosure":""},{"name":"Jonathan Kay,
MD","credentials":["Timothy S. and Elaine L. Peterson Chair in
Rheumatology\n","Professor of Medicine and Director of Clinical Research,
Rheumatology\n","University of Massachusetts Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences;
Pfizer [Felty's syndrome, rheumatoid arthritis (Infliximab-dyyb, tofacitinib)]; UCB
[Felty's syndrome, rheumatoid arthritis (Certolizumab pegol)]. Consultant/Advisory
Boards: Amgen [Felty's syndrome, rheumatoid arthritis (Adalimumab-atto, etanercept,
filgrastim)]; Boehringer Ingelheim [Felty's syndrome, rheumatoid arthritis];
Celgene; Celltrion Healthcare [Felty's syndrome, rheumatoid arthritis (Infliximab-
dyyb)]; Janssen Biotech [Felty's syndrome, rheumatoid arthritis [Infliximab]);
Merck [Felty's syndrome, rheumatoid arthritis]; Myriad Genetics [Felty's syndrome,
rheumatoid arthritis]; Pfizer [Felty's syndrome, rheumatoid arthritis (Infliximab-
dyyb, tofacitinib)]; Roche Laboratories [Felty's syndrome, rheumatoid arthritis
(Rituximab, tocilizumab)]; Samsung Bioepis [Felty's syndrome, rheumatoid
arthritis]; Sandoz [Felty's syndrome, rheumatoid arthritis (Etanercept-szzs,
filgrastim-sndz)]."},{"name":"Electron Kebebew, MD, FACS","credentials":["Senior
Investigator\n","Chief, Endocrine Oncology Branch\n","National Cancer
Institute\n","Professor of Surgery\n","George Washington University School of
Medicine & Health Sciences"],"disclosure":""},{"name":"Ellie Kelepouris, MD,
FAHA","credentials":["Professor of Medicine\n","Chief, Division of Nephrology and
Hypertension\n","Drexel University College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Mallinkrodt
[Nephrotic syndrome (ACTHar gel)]; Relypsa [Hyperkalemia (Veltassa)]; Mallinkdrodt
[Proteinuria (ACTHar gel)]; Mallinkrodt [Proteinuria ACTHar gel)].
Consultant/Advisory Boards: Relypsa [Hyperkalemia (Veltassa)]."},{"name":"Ramesh
Khanna, MD, FACP","credentials":["Karl D Nolph, MD Chair in Nephrology, Professor
of Medicine\n","Vice Chair, Department of Medicine\n","Director, Division of
Nephrology\n","University of Missouri-Columbia"],"disclosure":""},{"name":"Jan T
Kielstein, MD, FASN, FERA","credentials":["Assistant Professor of Medicine,
Hannover Medical School, Hannover, Germany\n","Director Medical Clinic V
(Nephrology, Rheumatology, Blood Purification), Academic Teaching Hospital,
Braunschweig, Germany"],"disclosure":""},{"name":"Talmadge E King, Jr,
MD","credentials":["Editor-in-Chief — Pulmonary and Critical Care
Medicine\n","Section Editor — Interstitial Lung Disease\n","Dean, School of
Medicine \n","Vice Chancellor, Medical Affairs\n","University of California San
Francisco"],"disclosure":""},{"name":"Christina L Klein, MD","credentials":
["Transplant Nephrologist\n","Piedmont Transplant
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [CMV (CMV
vaccine)]; Chimerix [CMV (Brincidofovir)]. Speaker's Bureau: Alexion [Atypical HUS
(Eculizumab)]. Consultant/Advisory Boards: Alexion [Atypical HUS (Eculizumab)]."},
{"name":"Paul E Klotman, MD","credentials":["President, CEO, and Executive
Dean\n","Baylor College of Medicine"],"disclosure":"Consultant/Advisory Boards:
98point6 [Clinical decision-making support]. Consultant/Advisory Boards
(spouse/partner): 98point6 [Clinical decision-making support]. Equity
Ownership/Stock Options: 98point6 [Clinical decision-making support]. Equity
Ownership/Stock Options (spouse/partner): 98point6 [Clinical decision-making
support]."},{"name":"Sidney M Kobrin, MD","credentials":["Associate Professor of
Medicine\n","University
of Pennsylvania"],"disclosure":""},{"name":"Robb D Kociol, MD","credentials":
["Associate Director\n","Advanced Heart Failure program\n","Beth Israel Deaconess
Medical Center\n","Instructor in Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Holly M Koncicki, MD","credentials":["Assistant
Professor \n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},
{"name":"Tal Kopel, MD","credentials":["Assistant Professor of Medicine\n","Centre
Hospitalier de l'Université de Montréal"],"disclosure":""},{"name":"Jeffrey B Kopp,
MD","credentials":["Senior Investigator, NIDDK, NIH\n","Adjunct Professor of
Medicine, Uniformed Services University of the Health Sciences"],"disclosure":""},
{"name":"Joel D Kopple, MD","credentials":["Professor of Medicine and Public
Health\n","David Geffen School of Medicine at UCLA and UCLA Fielding School of
Public Health\n","Los Angeles Biomedical Research Institute at Harbor - UCLA
Medical Center"],"disclosure":"Speaker's Bureau: Fresenius Kabi [Low protein diets
(Ketoacid supplements)]; Chugai Pharmaceuticals [Renal nutrition].
Consultant/Advisory Boards: Nephroceuticals; Fresenius Kabi [Vitamins]. Equity
Ownership/Stock Options: Nephroceuticals [Vitamins for chronic kidney disease
(Multivitamin tablets)]."},{"name":"Stephen M Korbet, MD","credentials":["Professor
of Medicine\n","Rush University Medical Center"],"disclosure":""},{"name":"Peter
Kotanko, MD","credentials":["Docent of Internal Medicine\n","Innsbruck Medical
University, Austria\n","Research Director\n","Renal Research Institute, New
York"],"disclosure":"Employment: Renal Research Institute [Nephrology (Dialysis)].
Equity Ownership/Stock Options: Fresenius Medical Care [Dialysis (Dialysis
equipment)]."},{"name":"Eugene C Kovalik, MD","credentials":["Associate Professor
of Medicine\n","Duke University Medical Center"],"disclosure":""},{"name":"Csaba P
Kovesdy, MD, FASN","credentials":["Professor of Medicine\n","University of
Tennessee Health Science Center"],"disclosure":""},{"name":"Michelle W Krause, MD,
MPH","credentials":["Professor of Medicine\n","University of Arkansas for Medical
Sciences"],"disclosure":""},{"name":"Jonathan B Kruskal, MD, PhD","credentials":
["Section Editor — Kidney Disease\n","Professor of Radiology\n","Harvard Medical
School"],"disclosure":""},{"name":"Abhijit V Kshirsagar, MD, MPH","credentials":
["Associate Professor of Medicine\n","University of North Carolina at Chapel
Hill"],"disclosure":""},{"name":"Aleksandra Kukla, MD","credentials":["Associate
Professor of Medicine\n","University of Minnesota"],"disclosure":""},
{"name":"Michael Kurtz, MD","credentials":["Instructor in Surgery\n","Children's
Hospital Boston"],"disclosure":""},{"name":"Shana Kusin, MD","credentials":
["Assistant Professor of Emergency Medicine and Medical Toxicology\n","Oregon
Health and Science University"],"disclosure":""},{"name":"Christopher H Kwoh,
MD","credentials":["The Kidney Institute and Renal Research,
Inc."],"disclosure":""},{"name":"Robert A Kyle, MD","credentials":["Section Editor
— Plasma Cell Disorders\n","Professor of Medicine\n","Mayo Medical
School"],"disclosure":"Consultant/Advisory Boards: Celgene Disease Monitoring
Committee [Dysproteinemias (lenalidomide, pomalidomide)]; Bristol-Myers Squibb
Independent Monitoring Committee [Dysproteinemias (elotuzumab)]; Onyx Pharma
(Amgen) Data Monitoring Committee [Dysproteinemias (carfilzomib)]; Pharmacyclics
Data Safety Monitoring Board [Dysproteinemias (ibrutinib)]. Other Financial
Interest: Pfizer [Lecture on therapy of multiple myeloma, made comments concerning
a new Pfizer product and received an honorarium]."},{"name":"Albert Q Lam,
MD","credentials":["Deputy Editor — Nephrology\n","Assistant Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Richard A Larson,
MD","credentials":["Editor-in-Chief — Hematology\n","Section Editor —
Leukemia\n","Professor of Medicine\n","University of Chicago Pritzker School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [leukemia
(gilteritinib)]; Erytech [leukemia (eryaspase)]; Novartis [leukemia (nilotinib,
ascininib)]; Daiichi Sankyo [leukemia (quizartinib)]; Celgene [leukemia
(enasidenib)]. Consultant/Advisory Boards: Novartis [leukemia (imatinib,
nilotinib)]; Ariad Data Safety Monitoring Board [leukemia (ponatinib)];
CVS/Caremark [leukemia (drug prior authorization program)]; Celgene Data Safety
Monitoring Board [leukemia (azacitidine, durvalumab)]; Amgen [leukemia
(blinatumomab)]; Astellas [leukemia (gilteritinib)]; Jazz [leukemia (CPX-351)]."},
{"name":"Geoffrey Lee, MD","credentials":["Attending Physician\n","Kingston General
Hospital"],"disclosure":""},{"name":"Michael D Leise, MD","credentials":["Assistant
Professor of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Hepatitis C
(Grazoprevir, elbasvir)]; Abbvie [Hepatitis C (Glecaprevir/Pibrentasvir)]."},
{"name":"Krista L Lentine, MD, PhD","credentials":["Professor of Medicine\n","Saint
Louis University School of Medicine"],"disclosure":"Equity Ownership/Stock Options:
XynManagement [Risk assessment software for transplant programs]."},{"name":"Edgar
V Lerma, MD, FACP, FASN, FAHA","credentials":["SGIM Peer Reviewer\n","Clinical
Professor of Medicine\n","University of Illinois at Chicago College of
Medicine"],"disclosure":""},{"name":"Nelson Leung, MD","credentials":["Professor of
Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Omeros Corporation
[thrombotic microangiopathy]. Consultant/Advisory Boards: Prothena [amyloidosis];
Thrasos Therapeutics [myeloma kidney (cast nephropathy)]."},{"name":"Andrew S
Levey, MD","credentials":["Dr. Gerald J. and Dorothy R. Friedman Professor
Emeritus\n","Professor of Medicine\n","Tufts University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH, NKF (CKD/GFR);
Astra Zeneca (DSMB). Patent Holder: Provisional patent [Coresh, Inker, Levey]
titled, “Precise estimation of glomerular filtration rate from multiple
biomarkers”, filed 8/15/2014. The technology is not licensed in whole or in part to
any company. Tufts Medical Center, John Hopkins University and Metabolon Inc have a
collaboration agreement to develop a product to estimate GFR from a panel of
markers."},{"name":"E Michael Lewiecki, MD","credentials":["Director\n","New Mexico
Clinical Research & Osteoporosis Center"],"disclosure":"Grant/Research/Clinical
Trial Support: Amgen [Osteoporosis (Denosumab, romosozumab). Speaker's Bureau:
Radius [Osteoporosis (Abaloparatide)]. Consultant/Advisory Boards: Amgen
[Osteoporosis (Denosumab, romosozumab); Radius [Osteoporosis (Abaloparatide)]."},
{"name":"Orfeas Liangos, MD, FASN","credentials":["Adjunct Assistant Professor of
Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"John C
Lieske, MD","credentials":["Professor of Medicine\n","Mayo Clinic Division of
Nephrology and Hypertension"],"disclosure":""},{"name":"Kee-Hak Lim,
MD","credentials":["Associate Professor of Obstetrics & Gynecology (part-
time)\n","Harvard Medical School"],"disclosure":""},{"name":"Ajit P Limaye, MD,
FACP, FIDSA","credentials":["Professor of Medicine\n","University of
Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [BKV
infection (Antibodies)]."},{"name":"Robert M Lindsay, MD, FRCPC,
FRCPE","credentials":["Professor, Schulich School of Medicine\n","Western
University, London, Canada"],"disclosure":""},{"name":"Cornelis J Lips, MD,
PhD","credentials":["Professor of Endocrinology and Metabolism\n","Department of
Internal Medicine\n","University Medical Center Utrecht, The
Netherlands"],"disclosure":""},{"name":"Mark Little, FRCP, PhD","credentials":
["Professor of Nephrology\n","Trinity College Dublin"],"disclosure":""},
{"name":"Anna SF Lok, MD","credentials":["Professor of Medicine\n","University of
Michigan Medical School"],"disclosure":"Grant/Research/Clinical Trial Support:
Gilead [HBV/HCV]; Bristol-Myers Squibb [HCV]; Merck [HCV]; Target Pharma [NAFL]."},
{"name":"Randy Luciano, MD, PhD","credentials":["Instructor in Medicine\n","Yale
University Medical School"],"disclosure":""},{"name":"Naim Maalouf,
MD","credentials":["Associate Professor of Medicine\n","University of Texas
Southwestern Medical Center"],"disclosure":"Other Financial Interest: Quest
Diagnostics [Osteoporosis (Educational webinar)]."},{"name":"Colm C Magee, MD, MPH,
FRCPI","credentials":["Clinical Lecturer in Medicine\n","Royal College of
Surgeons"],"disclosure":"Other Financial Interest: Astellas [Conference
support/hotel (American Transplant Congress)]."},{"name":"Lionel U Mailloux, MD,
FACP","credentials":["Clinical Professor of Medicine\n","Hofstra Northwell School
of Medicine"],"disclosure":""},{"name":"Andrew Malone, MB, BCh,
MRCPI","credentials":["Assistant Professor of Medicine, Division of
Nephrology\n","Department of Medicine, Washington University School of
Medicine"],"disclosure":""},{"name":"Jess Mandel, MD","credentials":["Section
Editor — Pulmonary Vascular Disease\n","Professor of Medicine\n","University of
California, San Diego"],"disclosure":""},{"name":"J Michael Mangrum,
MD","credentials":["Associate Professor of Medicine\n","University of
Virginia"],"disclosure":""},{"name":"Johannes FE Mann, MD","credentials":
["Professor of Medicine\n","Friedrich Alexander University of Erlangen-
Nürnberg\n","International Scholar, Population Health Research Institute, McMaster
University, Canada"],"disclosure":"Grant/Research/Clinical Trial Support:
NovoNordisk [Diabetes (insulin, liraglutide)]; European Union [diabetes]; Celgene
[anemia, bone disease]; Roche [anemia]; Vifor [hyperkalemia (patiromer)]; Relypsa
[hyperkalemia (patiromer)]. Speaker's Bureau: Astra [hyperkalemia]; Braun
[dialysis]; Fresenius [dialysis]; Gambro [dialysis]; Medice
[dialysis]; NovoNordisk [diabetes]; Relypsa [hyperkalemia]; Roche [anemia];
Boehringer [diabetes]. Consultant/Advisory Boards: Abbvie [diabetes]; Astra
[hyperkalemia, diabetes]; Celgene [anemia]; Fresenius [dialysis]; Lilly [diabetes];
NovoNordisk [diabetes]; Relypsa [hyperkalemia]; Sanofi [diabetes]; Vifor
[hyperkalemia]."},{"name":"Samuel J Mann, MD","credentials":["Professor of Clinical
Medicine\n","Division of Nephrology and Hypertension\n","NY Presbyterian Hospital –
Weill Cornell Medical College"],"disclosure":""},{"name":"Warren J Manning,
MD","credentials":["Section Editor — Noninvasive Cardiac Imaging and Stress
Testing\n","Professor of Medicine and Radiology\n","Harvard Medical
School"],"disclosure":"Patent Holder: Samsung Electronics [MRI]. Equity
Ownership/Stock Options: Pfizer [Anticoagulants]. Equity Ownership/Stock Options
(Spouse): General Electric [Cardiac imaging]."},{"name":"Stavros C Manolagas, MD,
PhD","credentials":["Professor of Medicine\n","University of Arkansas for Medical
Sciences"],"disclosure":"Ownership/Stock Options: Radius Health [Osteoporosis
therapy (Abaloparatide)]."},{"name":"Glen S Markowitz, MD","credentials":
["Professor of Clinical Pathology\n","Columbia University Medical
Center"],"disclosure":""},{"name":"Philip A Marsden, MD","credentials":["Professor
of Medicine\n","Vice-Chair, Department of Medicine at the University of Toronto,
Research\n","Oreopoulos-Baxter Division Director of Nephrology at the University of
Toronto"],"disclosure":""},{"name":"Tej K Mattoo, MD, DCH, FRCP","credentials":
["Section Editor — Pediatric Nephrology\n","Professor of Pediatrics\n","Wayne State
University School of Medicine"],"disclosure":""},{"name":"Michael Mauer,
MD","credentials":["Professor of Pediatrics and Medicine\n","University of
Minnesota Medical School"],"disclosure":"Grant/Research/Clinical Trial Support:
Sanofi/Genzyme; Amicus [Fabry disease (Agalsidase beta, migalastat).
Consultant/Advisory Boards: Sanofi/Genzyme [Fabry disease (Agalsidase beta)];
Amicus [Fabry disease (migalastat)]."},{"name":"Ivan D Maya, MD,
FACP","credentials":["Associate Professor of Medicine\n","University of Central
Florida"],"disclosure":""},{"name":"David K McCulloch, MD","credentials":
["Diabetologist\n","Washington Permanente Medical Group"],"disclosure":""},
{"name":"W. Joseph McCune, MD, MACR","credentials":["Michael H and Marcia S Klein
Professor of Rheumatic Diseases\n","Associate Chief, Division of
Rheumatology\n","Director, Lupus Program\n","University of
Michigan"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Lupus
(Anifrolumab)]; Eli Lilly [Lupus (Baricitinab)]; GlaxoSmithKline [Lupus
(Belimumab)]."},{"name":"Colin McDonald, MD","credentials":["Instructor in
Neurology\n","Harvard Medical School"],"disclosure":"Equity Ownership/Stock
Options: Specialists on Call [Medical Management (Emergency Neurology
Telemedicine)]."},{"name":"Ankit Mehta, MD","credentials":["Assistant Professor,
Department of Internal Medicine, Texas A&M College of Medicine,
Dallas\n","Associate Program Director, Internal Medicine Residency, Baylor
University Medical Center, Dallas"],"disclosure":""},{"name":"James B Meigs, MD,
MPH","credentials":["Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Jaime R Merchan, MD, MMSc","credentials":
["Associate Professor of Medicine\n","University of Miami Miller School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Agensys [Cancer
(ASG-22CE)]; Rexahn Pharmaceuticals [Cancer (RX-3117)]; Lilly [Cancer (LY3039478)];
Tracon [Cancer (TRC105)]; Acceleron [Cancer (Dalantarcept)]; Novartis [Cancer
(Trametinib/ribociclib)]. Consultant/Advisory Boards: Exelixis [Cancer
(cabozantinib)]."},{"name":"Angelo Mercieri, MD","credentials":["Internal Medicine
Unit\n","Head Physician of Emergencies Unit\n","Bolognini Hospital, Seriate,
Bergamo, Italy"],"disclosure":""},{"name":"Peter A Merkel, MD, MPH","credentials":
["Section Editor — Vasculitis\n","Chief, Division of Rheumatology\n","University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Actelion
[scleroderma]; Bristol-Myers Squibb [vasculitis (abatacept)]; Celgene [vasculitis
(apremilast)]; ChemoCentryx [vasculitis (avocopan)]; Genentech/Roche [vasculitis
(rituximab, tocilizumab)]; GlaxoSmithKline [vasculitis (belimumab, mepolimumab,
sirukumab)]; Kypha [vasculitis]; MedImmune [vasculitis]; TerumoBCT [vasculitis].
Consultant/Advisory Boards: Abbvie [vasculitis]; Actelion [scleroderma]; Bristol-
Myers Squibb [vasculitis]; Beoringher Ingelheim [scleroderma]; ChemoCentryx
[vasculitis (avocopan)]; Genentech/Roche[vasculitis (rituximab, tocilizumab)];
GlaxoSmithKline [vasculitis (belimumab, mepolimumab)]; InflaRx [vasculitis];
PrincipiaBio [vasculitis]; Prothena [vasculitis]; Seattle Genetics [vasculitis]."},
{"name":"Joseph F Merola, MD, MMSc, FAAD, FACR","credentials":["Assistant
Professor, Harvard Medical School\n","Department of Dermatology\n","Department of
Medicine, Division of Rheumatology \n","Brigham and Women's
Hospital"],"disclosure":"Grant/Research Support: Biogen [Cutaneous lupus
erythematosus]; Pfizer [Psoriatic arthritis (Tofacitinib)]; Boehringer Ingelheim
Pharmaceuticals [Psoriasis (Ustekinumab)]; Eli Lily and Company [Psoriasis
(Ixekizumab)]. Speakers Bureau: AbbVie [Psoriasis (Adalimumab)].
Consultant/Advisory Boards: Biogen [Cutaneous lupus erythematosus]; AbbVie
[Psoriasis, psoriatic arthritis (Adalimumab)]; Amgen [Psoriasis, psoriatic
arthritis (Etanercept)]; Eli Lilly and Company [Psoriasis, psoriatic arthritis
(Tofacitinib)]; Novartis [Psoriasis, psoriatic arthritis (Secukinumab)]; Pfizer
[Psoriasis, psoriatic arthritis (Tofacitinib)]; Janssen Pharmaceutica [Psoriasis,
psoriatic arthritis (Ustekinumab)]; Momenta Pharmaceuticals [Connective tissue
disease]; Mallinckrodt Pharmaceuticals [Psoriasis, psoriatic arthritis (Repository
corticotropin injection)]. Patent Holder: AbbVie [Psoriasis (Licensed outcome
measure)]."},{"name":"Theo E Meyer, MD, PhD","credentials":["Professor of
Medicine \n","Chief, Clinical Cardiology \n","Director, Advanced Heart Failure
Program \n","University of Massachusetts Medical School \n","UMassMemorial Medical
Center"],"disclosure":""},{"name":"Alain Meyrier, MD","credentials":["Professor of
Medicine (Emeritus)\n","Université Paris-Descartes, Paris,
France"],"disclosure":""},{"name":"Brent W Miller, MD","credentials":["Professor of
Medicine\n","Washington University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Fresenius Medical Care
[Dialysis (Dialysis centers, equipment, and supplies)]."},{"name":"Paul D Miller,
MD","credentials":["Distinguished Clinical Professor of Medicine\n","University of
Colorado Health Sciences Center"],"disclosure":"Grant/Research/Clinical Trial
Support: Alexion; Amgen; Boehringer Ingelheim; Immunodiagnostics; Eli Lilly &
Company; Merck; Merck Serrano; National Bone Health Alliance; Novartis; Radius
Pharma; Roche Diagnostics; Regeneron; Ultragenyx [Osteoporosis, Osteoarthritis,
HPP, TIO, Type II diabetes, Fracture studies, Renal bone disease].
Consultant/Advisory Boards/ Data Safety Committee: Allergan Pharmaceuticals;
Grünenthal Group; Amgen; AgNovos; Lilly; Merck; Radius Pharma; Roche; Ultragenyx
[Osteoporosis, Osteoarthritis, HPP, TIO, Osteogenesis imperfect, Renal bone
disease, Bone in type II diabetes]."},{"name":"Dana Miskulin, MD","credentials":
["Associate Professor\n","Tufts University School of Medicine"],"disclosure":""},
{"name":"Madhukar Misra, MD, FRCP","credentials":["Professor of
Medicine\n","University of Missouri School of Medicine,
Columbia"],"disclosure":""},{"name":"Bruce A Molitoris, MD","credentials":
["Professor of Medicine\n","Indiana University School of
Medicine"],"disclosure":"Patent Holder: La Jolla Pharmaceuticals [Gentamicin
(Nontoxic gentamicin congener)]."},{"name":"Michael A Mont, MD","credentials":
["Chair, Orthopaedic Surgery\n","Cleveland
Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: DJO Global
[Osteoarthritis (braces)]; Johnson and Johnson [Sutures]; National Institutes of
Health [Prostheses explant]; Ongoing Care Solutions [Osteoarthritis (Braces)];
Orthosensor [Joint replacement sensor]; Stryker [Joint replacement prostheses];
TissueGene [Osteoarthritis (TissueGene-C)]. Consultant/Advisory Boards: DJO Global
[Osteoarthritis (braces)]; Johnson and Johnson [Sutures]; Orthosensor [Joint
replacement sensor]; Pacira [Pain control (Liposomal bupivacaine)]; Sage [Infection
prevention (Chlorhexidine cloth)]; Stryker [Joint replacement prostheses];
Mallinckrodt Pharmaceuticals [Pain control medication]; Abbott [Medications]. Other
financial interest: Microport [IP royalties]; Stryker [IP royalties]."},
{"name":"James P Morgan, MD, PhD","credentials":["Professor of Medicine\n","Tufts
University School of Medicine"],"disclosure":""},{"name":"R Sean Morrison,
MD","credentials":["Section Editor — Selected End Stage Conditions\n","Hermann
Merkin Professor of Palliative Care\n","Mount Sinai School of
Medicine"],"disclosure":""},{"name":"David B Mount, MD","credentials":["Assistant
Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Ardea [Urate
transport (Lesinurad)]. Consultant/Advisory Boards: ZS Pharma [Potassium (ZS9)];
Relypsa [Potassium (Patiromer)]."},{"name":"Marion Muche, MD","credentials":
["Charité - Medical University, Berlin, Germany"],"disclosure":""},{"name":"Istvan
Mucsi, MD, PhD","credentials":["Associate Professor of Medicine\n","Department of
Medicine (Nephrology), University of Toronto"],"disclosure":""},{"name":"Bruce A
Mueller, PharmD, FCCP, FASN, FNKF","credentials":["Professor and Associate Dean of
Academic Affairs\n","University of Michigan College of
Pharmacy"],"disclosure":"Grant/Research/Clinical Trial Support: Baxter [CRRT
solution]; Merck [Infections (Imipenem/relecactam)];
Cidara Therapeutics [CD101]; MediBeacon [MB102]. Speaker's Bureau: NxStage [SHIFT
dialysis]; Baxter [Dialysis]. Employment (spouse/partner): CVS."},{"name":"Jukka
Mustonen, MD, PhD","credentials":["Emeritus Professor of Internal
Medicine\n","University of Tampere\n","Medical Adviser\n","Tampere University
Hospital"],"disclosure":""},{"name":"Tibor Nadasdy, MD","credentials":["Professor
of Pathology\n","Director of Renal and Transplant Pathology \n","Ohio State
University"],"disclosure":""},{"name":"Samih H Nasr, MD","credentials":["Professor
of Laboratory Medicine and Pathology\n","College of Medicine, Mayo
Clinic"],"disclosure":""},{"name":"Robert S Negrin, MD","credentials":["Section
Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Stanford
University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen
[Immuno-oncology]; Jazz Pharmaceuticals [Veno-occlusive disease (Defibrotide)];
Cell Source [Cellular therapy]; Magenta Pharmaceuticals [Transplantation]. Equity
Ownership/Stock Options: Concentrx [Cellular immunotherapy]; Magenta
Pharmaceuticals [Transplantation]; Cell Source [Cellular therapy]. Other Financial
Interest: American Society of Hematology [Editor in Chief of \"Blood
Advances\"]."},{"name":"Peter J Nelson, MD","credentials":["Associate Professor of
Medicine\n","University of Washington School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Retrophin [Glomerular disease
(Sparsentan)]."},{"name":"Gihad E Nesrallah, MD, MSc, FRCPC, FACP","credentials":
["Adjunct Professor\n","Western University"],"disclosure":""},{"name":"Patrick
Niaudet, MD","credentials":["Section Editor — Pediatric Nephrology\n","Professor of
Pediatrics\n","Hôpital Necker-Enfants Malades, Paris, France"],"disclosure":""},
{"name":"Thomas Nickolas, MD, MS","credentials":["Associate Professor of
Medicine\n","Training Program Directory, Nephrology\n","Columbia University Medical
Center, Department of Medicine, Nephrology"],"disclosure":"Grant/Research/Clinical
Trial Support: Amgen [Bone tissue and calcification propensity in end-stage kidney
disease (Etelcalcetide)]."},{"name":"Sagar U Nigwekar, MD, MMSc","credentials":
["Instructor in Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Hope Pharma
[Calciphylaxis (Sodium thiosulfate)]. Other Financial Interest: Sanofi-Aventis
[Calciphylaxis (Sevelamer, Doxercalciferol)] (speaking fees)."},{"name":"Marta
Novak, MD, PhD","credentials":["Associate Professor of Psychiatry\n","University of
Toronto, Canada"],"disclosure":""},{"name":"Gregorio T Obrador, MD,
MPH","credentials":["Adjunct Assistant Professor of Medicine \n","Tufts University
School of Medicine\n","Dean and Professor of Medicine\n","Universidad Panamericana
School of Medicine"],"disclosure":""},{"name":"Iheanyichukwu Ogu,
MD","credentials":["Assistant Professor of Medicine, Section of
Nephrology\n","Marshall Kidney Care and Hypertension Center\n","Marshall University
School of Medicine"],"disclosure":""},{"name":"Ann M O'Hare, MD","credentials":
["Associate Professor of Medicine\n","University of Washington School of
Medicine"],"disclosure":""},{"name":"Mark D Okusa, MD","credentials":["Professor of
Medicine\n","University of Virginia Health
System"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [AKI]; John Bower
Foundation [AKI]; Pfizer [Acute kidney injury (Recombinant alkaline phosphatase)].
Consultant/Advisory Boards: AM Pharma [AKI]. Patent Holder: B2 pharmaceutical
compositions having A2A adenosine receptor agonist activity; Methods and
compositions for treating inflammatory response. Equity Ownership/Stock Options:
Adenosine Therapeutics [AKI]."},{"name":"Jeffrey W Olin, DO","credentials":
["Professor of Medicine (Cardiology)\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":""},{"name":"Matthew J Oliver, MD, MHS","credentials":
["Associate Professor of Medicine\n","University of Toronto,
Canada"],"disclosure":"Equity Ownership/Stock Options: Oliver Medical Management
[Vascular access (software measuring dialysis program performance)]."},{"name":"W
Charles O'Neill, MD","credentials":["Professor of Medicine\n","Emory University
School of Medicine"],"disclosure":""},{"name":"Thomas L Ortel, MD,
PhD","credentials":["Professor of Medicine & Pathology\n","Hemostasis & Thrombosis
Center, Duke University"],"disclosure":"Grant/Research/Clinical Trial Support:
Instrumentation Laboratory [coagulation laboratory testing (coagulation laboratory
test instruments and reagents)]; Stago [coagulation laboratory testing (coagulation
laboratory test instruments and reagents)]; Siemens [coagulation laboratory testing
(coagulation laboratory test instruments and reagents)]."},{"name":"James Owens,
MD, PhD","credentials":["Associate Professor of Neurology\n","Adjunct Associate
Professor of Pediatrics\n","University of Washington School of
Medicine"],"disclosure":""},{"name":"Alison M Pack, MD","credentials":["Associate
Professor of Clinical Neurology\n","Columbia University College of Physicians and
Surgeons"],"disclosure":""},{"name":"Vernon M Pais, Jr, MD","credentials":
["Associate Professor of Surgery/Urology\n","Geisel School of Medicine at
Dartmouth"],"disclosure":""},{"name":"Paul M Palevsky, MD","credentials":["Section
Editor — Renal Failure\n","Professor of Medicine\n","University of
Pittsburgh\n","VA Pittsburgh Healthcare
System"],"disclosure":"Grant/Research/Clinical Trial Support: Spectral Medical
[Sepsis (Endotoxin assay)]. Consultant/Advisory Boards: Baxter [Dialysis
(Hemodialysis equipment, peritoneal dialysis equipment and supplies, continuous
renal replacement therapy equipment and solutions)]; Durect [Potential agent for
AKI]; HealthSpan Dx [Novel diagnostic test for prediction of AKI]; GE Healthcare
[Radiocontrast agents and equipment]."},{"name":"Biff F Palmer, MD","credentials":
["Professor of Internal Medicine\n","University of Texas Southwestern Medical
Center"],"disclosure":""},{"name":"Alessandra Palmisano, MD, PhD","credentials":
["Department of Clinical and Experimental Medicine\n","University of Parma,
Italy"],"disclosure":""},{"name":"Shubham Pant, MD","credentials":["Associate
Professor\n","Associate Medical Director of The Clinical & Translational Research
Center\n","MD Anderson Cancer Center"],"disclosure":""},{"name":"Chirag Parikh, MD,
PhD","credentials":["Professor of Medicine\n","Yale University School of
Medicine"],"disclosure":""},{"name":"Samir M Parikh, MD","credentials":["Associate
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Samir
V Parikh, MD","credentials":["Assistant Professor of Clinical Medicine\n","Division
of Nephrology\n","The Ohio State University Medical
Center"],"disclosure":"Consultant/Advisory Boards: Alexion Pharmaceuticals
[Atypical HUS (Eculizumab)]; Aurinia Pharmaceuticals [Lupus nephritis
(Voclosporin)]."},{"name":"Rod Passman, MD, MSCE","credentials":["Professor of
Medicine\n","Northwestern University Feinberg School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol-Myers
[Anticoagulation]; Kardia [Cardiac monitoring]. Speaker's Bureau: Biotronik
[Implantable cardiac monitors]; Medtronic [Implantable Cardiac Monitors (Cardiac
monitors)]. Consultant/Advisory Boards: Medtronic [Implantable cardiac
monitors]."},{"name":"Sassan Pazirandeh, MD","credentials":["Division of
Gastroenterology and Hepatology\n","Kaiser Permanente Medical
Center"],"disclosure":""},{"name":"York Pei, MD, FRCPC, FACP, FASN","credentials":
["Professor of Medicine\n","University Health Network and University of
Toronto"],"disclosure":""},{"name":"William F Pendergraft III, MD,
PhD","credentials":["Assistant Professor of Medicine, University of North Carolina
Kidney Center\n","Visiting Postdoctoral Scholar, Hacohen Group, Broad Institute of
Harvard and MIT"],"disclosure":""},{"name":"Mark A Perazella, MD,
FACP","credentials":["Professor of Medicine\n","Yale University School of
Medicine"],"disclosure":""},{"name":"Leigh Perreault, MD","credentials":["Associate
Professor of Medicine\n","University of Colorado Anschutz Medical
Campus\n","Associate Professor of Epidemiology\n","Colorado School of Public
Health"],"disclosure":"Speaker's Bureau: Novo Nordisk [Obesity (Liraglutide
injection)]; Orexigen Therapeutics, Inc [Obesity (naltrexone HCl/bupropion HCl)].
Consultant/Advisory Boards: Novo Nordisk [Obesity (Liraglutide injection)]."},
{"name":"Ronald D Perrone, MD","credentials":["Section Editor — Cystic
Disease\n","Professor of Medicine\n","Tufts University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [Polycystic
kidney disease (Tolvaptan)]; Kadmon [Polycystic kidney disease (Tesevatinib)];
Department of Defense [Polycystic kidney disease (Metformin)]. Consultant/Advisory
Boards: Otsuka [Polycystic kidney disease (Tolvaptan)]; Novartis [Polycystic kidney
disease]; Misubishi Tanabe [Polycystic kidney disease]; Sanofi-Genzyme [Polycystic
kidney disease]."},{"name":"Holly Perry, MD","credentials":["Assistant Professor of
Pediatrics\n","Tufts University School of Medicine"],"disclosure":""},
{"name":"Andreas Pierratos, MD, FRCPC","credentials":["Professor of
Medicine\n","University of Toronto, Canada"],"disclosure":""},{"name":"Nicole A
Pilch, PharmD, MSCR, BCPS","credentials":["Clinical Specialist\n","Medical
University of South Carolina"],"disclosure":""},{"name":"Duane S Pinto, MD,
MPH","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic
[Stents/TAVR (Resolute/Evolut)]; Medicines [ACS (Bivalirudin/Cangrelor)]; Boston
Scientific [Coronary stents]; Amarin [Clinical trial event adjudication].
Consultant/Advisory Boards: Abiomed [Circulatory support]; Boston Scientific
[Coronary stents]; Terumo [Catheters]."},{"name":"Jeffrey L Platt,
MD","credentials":["Professor
of Surgery and Microbiology and Immunology\n","University of
Michigan"],"disclosure":""},{"name":"Sharon E Plon, MD, PhD","credentials":
["Professor, Departments of \n","Pediatrics/Hematology-Oncology\n","Molecular and
Human Genetics\n","Human Genome Sequencing Center\n","Baylor College of
Medicine"],"disclosure":"Consultant/Advisory Boards: Baylor Genetics Laboratories
[genetic testing (hereditary cancer genetic testing)]."},{"name":"Philip J Podrid,
MD, FACC","credentials":["Professor of Medicine, Professor of Pharmacology and
Experimental Therapeutics \n","Boston University School of Medicine\n","Lecturer,
Harvard Medical School"],"disclosure":""},{"name":"Marc A Pohl, MD","credentials":
["Ray W. Gifford, Jr., MD Endowed Chair in Hypertension\n","Nephrology and
Hypertension\n","Cleveland Clinic"],"disclosure":""},{"name":"Didier Portilla,
MD","credentials":["Professor of Medicine\n","University of
Virginia"],"disclosure":""},{"name":"Raoul Poupon, MD","credentials":["Professor of
Hepatology and Gastroenterology\n","University Pierre et Marie Curie\n","UPMC,
Sorbonne University, Paris, France"],"disclosure":"Consultant/Advisory Boards:
Intercept Pharma."},{"name":"Manuel Praga, MD, PhD","credentials":["Professor of
Medicine\n","Complutense University, Madrid"],"disclosure":"Speaker's Bureau:
Alexion [Hemolytic uremic syndrome (Eculizumab)]; Otsuka [Polycystic kidney disease
(Tolvaptan)]; Fresenius [Hemodialysis]. Consultant/Advisory Boards: Alexion
[Hemolytic uremic syndrome (Eculizumab)]; Otsuka [Polycystic kidney disease
(Tolvaptan)]; Fresenius [Hemodialysis]."},{"name":"Glenn M Preminger,
MD","credentials":["Section Editor — Renal Ureteral Stones\n","Professor of
Urologic Surgery\n","Duke University Medical Center\n","Director of
Education\n","Endourological Society"],"disclosure":"Consultant/Advisory Boards:
Retrophin [Cystine stones (Tiopronin)]; Boston Scientific [Surgical stone
management (Endourology equipment)]."},{"name":"Ching-Hon Pui, MD","credentials":
["Chair of the Department of Oncology\n","Fahad Al-Rashid Chair of Leukemia
Research\n","St. Jude's Children's Hospital\n","American Cancer Society
Professor \n","Professor of Pediatrics\n","University of Tennessee Health Science
Center"],"disclosure":"Consultant/Advisory Boards: Adaptive Biotechnologies [Deep
sequencing for minimal residual disease detection]."},{"name":"Charles D Pusey,
MD","credentials":["Professor of Medicine\n","Imperial College,
London"],"disclosure":""},{"name":"L Darryl Quarles, MD","credentials":["Section
Editor — Renal Osteodystrophy\n","Director, Division of Nephrology\n","Associate
Dean for Research\n","The University of Tennessee Health Science
Center"],"disclosure":"Speaker's Bureau: Amgen [Calcimimetic (Cinacalcet)]."},
{"name":"Wajeh Y Qunibi, MD","credentials":["Professor of Medicine\n","University
of Texas Health Sciences Center"],"disclosure":""},{"name":"Jai Radhakrishnan, MD,
MS","credentials":["Professor of Medicine\n","Columbia University Medical
Center"],"disclosure":""},{"name":"Hershel Raff, PhD","credentials":["Professor of
Medicine\n","Medical College of Wisconsin"],"disclosure":"Consultant/Advisory
Boards: Millendo, Corcept, Cerium [laboratory testing for HPA axis disorders]."},
{"name":"Frederic F Rahbari-Oskoui, MD, MSCR","credentials":["Associate Professor
of Medicine\n","Emory University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [ADPKD
(Tolvaptan)]; Kadmon [ADPKD (Tesevatinib)]. Consultant/Advisory Boards: Kadmon
[ADPKD (Tesevatinib)]."},{"name":"S Vincent Rajkumar, MD","credentials":["Edward W.
and Betty Knight Scripps Professor of Medicine\n","Mayo Clinic"],"disclosure":""},
{"name":"Emilio Ramos, MD, FACP","credentials":["Clinical Professor of
Medicine\n","University of Buffalo, School of Medicine\n","Buffalo,
NY"],"disclosure":""},{"name":"Stephanie Randle, MD, MS","credentials":["Clinical
Assistant Professor of Pediatric Neurology and Epilepsy\n","University of
Washington and Seattle Children's Hospital"],"disclosure":""},{"name":"Jochen
Reiser, MD, PhD","credentials":["The Ralph C Brown MD Professor\n","Chairman of
Medicine\n","Rush University"],"disclosure":"Grant/Research/Clinical Trial Support:
NIH [nephrology (Kidney Disease)]. Consultant/Advisory Boards: Astellas [nephrology
(lecture about mechanisms of Kidney disease)]; Questcor [nephrology (lecture about
mechanisms of kidney disease)]; Mass General Hospital [nephrology (consultant to
research laboratory design and programs in nephrology)]. Patent Holder: TRISAQ [Co-
founder/stock holder (Development of bio device for removal of circulating factor
in FSGS)]. Equity Ownership/Stock Options: [Co-founder/stock holder (Development of
bio device for removal of circulating factor in FSGS)]."},{"name":"Sean H Rhyee,
MD, MPH","credentials":["Assistant Professor of Emergency Medicine, Division of
Medical Toxicology\n","University of Massachusetts Medical
School"],"disclosure":""},{"name":"Jerome P Richie, MD, FACS","credentials":
["Section Editor — Cancer of the Urethra, Penis, and Ureter; Urologic Surgery;
Prostate Cancer\n","Elliott Carr Cutler Professor of Surgery\n","Harvard Medical
School"],"disclosure":""},{"name":"Gianfranco Rizzato, MD","credentials":["Primario
Emerito Internal Medicine\n","Niguarda Hospital (Piazza Ospedale
Maggiore)"],"disclosure":""},{"name":"Darren M Roberts, MBBS, PhD,
FRACP","credentials":["Clinical Toxicologist, Royal Prince Alfred
Hospital\n","Nephrologist, Canberra Hospital\n","Associate Professor, Australian
National University"],"disclosure":""},{"name":"Dario Roccatello,
MD","credentials":["Professor of Nephrology and Clinical Pathology\n","University
of Turin Medical School"],"disclosure":"Consultant/Advisory Boards: Genzyme
[Eliglustat (Gaucher Disease)]."},{"name":"Michael Rocco, MD, MS","credentials":
["Professor of Medicine\n","Wake Forest University School of
Medicine"],"disclosure":""},{"name":"Richard J Rodeheffer, MD","credentials":
["Professor of Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"Rebecca
Rojas, MD","credentials":["Associate Professor of Internal Medicine\n","Medical
Director, Kidney Pre-transplantation, Department of Nephrology\n","University of
Texas Southwestern Medical Center"],"disclosure":""},{"name":"Pierre Ronco, MD,
PhD","credentials":["Professor of Renal Medicine\n","Pierre et Marie Curie
University, France"],"disclosure":"Grant/Research/Clinical Trial Support: AMGEN
[Rare genetic diseases of the kidney]; Alexion [Membranous Nephropathy
(Eculizumab)]."},{"name":"Guy Rordorf, MD","credentials":["Associate Professor of
Neurology\n","Harvard Medical School"],"disclosure":""},{"name":"Clifford J Rosen,
MD","credentials":["Section Editor — Bone Disease\n","Professor of
Nutrition\n","University of Maine\n","Professor of Medicine\n","Tufts University
School of Medicine"],"disclosure":""},{"name":"Harold N Rosen, MD","credentials":
["Associate Professor in Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Mark Rosenberg, MD","credentials":["Professor of Medicine\n","University
of Minnesota Medical School"],"disclosure":""},{"name":"Mitchell H Rosner,
MD","credentials":["Professor of Medicine\n","University of Virginia Health
System"],"disclosure":""},{"name":"Douglas S Ross, MD","credentials":["Section
Editor — Thyroid Disease\n","Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Board: Medullary Thyroid Cancer Registry
Consortium [Thyroid cancer]; Shire [Hypoparathyroidism (Parathyroid hormone for
injection)]; Spectrix Therapeutics, LLC [Hypothyroidism (Thyroid hormone)]. Other
Financial Interests: Abbott India (honorarium) [Hyperthyroidism (carbimazole,
levothyroxine)]; Quest Diagnostics (honorarium) [Hyperthyroidism]."},{"name":"Ana P
Rossi, MD, MPH","credentials":["Transplant Nephrologist, Maine Transplant
Program\n","Maine Medical Center"],"disclosure":""},{"name":"Lionel Rostaing, MD,
PhD","credentials":["Department of Nephrology, Hemodialysis, Apheresis, and Renal
Transplantation\n","Grenoble Alpes University Hospital,
France"],"disclosure":"Grant/Research Support: Hemat; Teriemo; Chiesi; Novartis;
Astellas; Neovii."},{"name":"Brad H Rovin, MD","credentials":["Section Editor —
Glomerular Diseases \n","Professor of Medicine and Pathology\n","The Ohio State
University College of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: NIH [Glomerular Diseases/Molecular Interrogation of Kidney Biopsies,
Precision Medicine/Biomarkers]. Consultant/Advisory Boards: Alexion [Lupus
Nephritis (Eucluzimab)]; Aurinia [Lupus Nephritis, FSGS (Voclosporin)]; Biogen Idec
[Lupus Nephritis (Anti-TWEAK)]; Biomarin [Hereditary Disorders of Metabolic
Disorders (Pegvaliase)]; Bristol Myers Squibb [FSGS, MCD (Abatacept)]; Chemocentryx
[Lupus Nephritis, ANCA Vasculitis, C3 Glomerulopathy (Avacopan)]; EMD Serono [IgA
Nephropathy (Atacicept)]; Frazier Life Sciences [Lupus Nephritis]; Genentech [Lupus
Nephritis, ANCA Vasculitis (Rituximab, Obinutuzumab)]; Lupus Foundation of America
[Lupus Nephritis]; Mallinkrodt [Lupus Nephritis, FSGS (ACTHAR Gel)]; Medimmune
[Lupus Nephritis (Anti-interferon)]; Novartis [IgA Nephropathy (Factor B
Inhibitor)]; Pharmalink [IgA Nephropathy]; Retrophin [IgA Nephropathy
(Sparsenten)]; Rigel [IgA Nephropathy (Fostamatinib])."},{"name":"Michael R
Rudnick, MD","credentials":["Associate Professor of Medicine\n","University of
Pennsylvania School of Medicine"],"disclosure":""},{"name":"Andrew D Rule, MD,
MSc","credentials":["Professor of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":""},{"name":"Bruce A Runyon, MD","credentials":["Section
Editor — Cirrhosis and Its Complications\n","Special Hepatology Consultant to the
Indian Health Service \n","Northern Navajo Medical Center, Shiprock, New
Mexico"],"disclosure":""},{"name":"Kenneth G Saag, MD, MSc","credentials":
["Professor
of Medicine\n","University of Alabama at
Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen
[Osteoporosis]; Ironwood/AstraZeneca [Gout]; Merck [Osteoporosis]; Takeda [Gout];
Horizon [Gout]; SOBI [Gout]. Consultant/Advisory Boards: Ironwood/AstraZeneca
[Gout, rheumatoid arthritis]; Takeda [Gout]; Amgen [Osteoporosis, rheumatoid
arthritis]; Merck [Osteoporosis, rheumatoid arthritis]; Abbott [Rheumatoid
arthritis]; Bristol-Myers Squibb [Rheumatoid arthritis]; Pfizer [Rheumatoid
arthritis]; Roche-Genentech [Rheumatoid arthritis]; Bayer [Rheumatoid arthritis];
Horizon [Gout]; Radius [Osteoporosis]; SOBI [Gout]; Lilly [Osteoporosis]."},
{"name":"A Mazin Safar, MD","credentials":["Associate Professor of
Medicine\n","University of Arkansas for Medical Sciences"],"disclosure":""},
{"name":"Takao Saito, MD, PhD","credentials":["Professor Emeritus, Fukuoka
University\n","Director, Sanko Clinic\n","Specified Medical Corporation Sanko
Group"],"disclosure":"Speaker's Bureau: Daiichi-Sankyo [Dyslipidemia
(Pravastatin)]; AstraZeneca [Dyslipidemia (Rosuvastatin)]; Kowa [Dyslipidemia
(Pitavastatin)]."},{"name":"David J Salant, MD","credentials":["Professor of
Medicine\n","Boston University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer CTI [Kidney
disease]. Consultant/Advisory Boards: Visterra [Glomerular disease]; Genzyme/Sanofi
[Membranous nephropathy (Agalsidase-beta)]; Pfizer [Data monitoring board for anti-
inflammatory drug trial]; Chugai [models of kidney fibrosis]. Patent Holder: Boston
Medical Center [Diagnostics for membranous nephropathy]."},{"name":"Neil S
Sanghani, MD","credentials":["Assistant Professor of Medicine\n","Vanderbilt
University Medical Center"],"disclosure":""},{"name":"Carlos AQ Santos, MD,
MPHS","credentials":["Associate Professor of Medicine\n","Rush University Medical
Center"],"disclosure":""},{"name":"Mark Sarnak, MD","credentials":["Professor of
Medicine\n","Tufts University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Akebia steering committee
[Hypoxia inducible factor therapy]."},{"name":"Deirdre Sawinski, MD,
FAST","credentials":["Assistant Professor of Medicine\n","Assistant Medical
Director, Kidney Pancreas Transplantation\n","Renal Electrolyte and Hypertension
Division\n","Hospital of the University of
Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Merck [HW treatment
(elbasvir-grazoprevir)]."},{"name":"Steven J Scheinman, MD","credentials":
["President and Dean, Professor of Medicine\n","Geisinger Commonwealth School of
Medicine"],"disclosure":""},{"name":"Jane O Schell, MD","credentials":["Assistant
Professor of Medicine\n","University of Pittsburgh School of
Medicine"],"disclosure":""},{"name":"Raphael Schiffmann, MD, MHSc","credentials":
["Director of the Institute of Metabolic Disease\n","Adjunct Professor of
Biomedical Studies\n","Baylor University Medical
Center"],"disclosure":"Grant/Research Support: Shire [Fabry disease (Agalsidase
alfa); Protalix [Fabry disease (PRX-102); Amicus [Fabry disease (Migalastat)];
Sanofi Genzyme [Gaucher disease type 3 (Venglustat)]. Consultant/Advisory Boards:
Protalix [Fabry disease (PRX-102)]; Amicus Therapeutics [Fabry disease
(Migalastat)]."},{"name":"Rebecca J Schmidt, DO, FACP","credentials":["Professor of
Medicine\n","West Virginia University School of Medicine"],"disclosure":""},
{"name":"Peter H Schur, MD","credentials":["Editor-in-Chief —
Rheumatology\n","Section Editor — Basic Science\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Marvin I Schwarz,
MD","credentials":["Professor of Medicine\n","University of Colorado Denver, School
of Medicine"],"disclosure":""},{"name":"Francesco Scolari, MD","credentials":
["Professor of Nephrology\n","University of Brescia"],"disclosure":""},
{"name":"Sanjeev Sethi, MD, PhD","credentials":["Professor of Laboratory Medicine
and Pathology\n","Mayo Clinic College of Medicine"],"disclosure":""},
{"name":"Mehmet S Sever, MD","credentials":["Professor of Medicine\n","Istanbul
School of Medicine"],"disclosure":"Consultant/Advisory Boards: Fresenius Medical
Care Turkey [Chronic hemodialysis patients treatment]. Other Financial Interest:
Amgen [Chronic kidney disease-mineral bone disease]."},{"name":"Daniel J Sexton,
MD","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor —
Bacterial Infections\n","Professor of Medicine\n","Duke University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Centers for Disease
Control and Prevention; National Institutes of Health [Healthcare epidemiology].
Consultant/Advisory Boards: Sterilis [Medical waste disposal]; Magnolia Medical
Technologies [Medical diagnostics]; National Football League [Infection
prevention]; Johnson & Johnson [Mesh-related infections]. Equity Ownership/Stock
Options: Magnolia Medical Technologies [Medical diagnostics (Blood culture
techniques)]. Other Financial Interest: Johnson & Johnson [Mesh-related
infections]."},{"name":"Elizabeth Shane, MD","credentials":["Professor of
Medicine\n","Columbia University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis
(denosumab)]. Consultant/Advisory Boards: Amgen [Osteoporosis (denosumab)]."},
{"name":"Melissa L Shannon, MD","credentials":["Staff Physician\n","Catholic Health
Initiatives\n","St Vincent Health System"],"disclosure":""},{"name":"Charles L
Shapiro, MD","credentials":["Professor of Medicine\n","Director of Translational
Breast Cancer Research\n","Director of Cancer Survivorship, Tisch Cancer
Institute"],"disclosure":""},{"name":"Ron Shapiro, MD","credentials":["Professor of
Surgery\n","Surgical Director, Kidney/Pancreas Transplant Program\n","Mount Sinai
Hospital - Recanati Miller Transplantation Institute"],"disclosure":""},
{"name":"Alice M Sheridan, MD","credentials":["Deputy Editor —
Nephrology\n","Assistant Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Richard A Sherman, MD","credentials":["Professor
of Medicine\n","Rutgers - Robert Wood Johnson Medical
School"],"disclosure":"Consultant/Advisory Boards: Merck [Hepatitis C (Elbasvir and
grazoprevir)]."},{"name":"Baha M Sibai, MD","credentials":["Professor, Maternal-
Fetal Medicine Division\n","Department of Obstetrics, Gynecology and Reproductive
Sciences\n","The University of Texas Medical School at Houston"],"disclosure":""},
{"name":"Edward D Siew, MD, MSCI","credentials":["Assistant Professor of
Medicine\n","Division of Nephrology and Hypertension, Vanderbilt Center for Kidney
Disease (VCKD)\n","Vanderbilt University Medical Center"],"disclosure":""},
{"name":"Shonni J Silverberg, MD","credentials":["Professor of
Medicine\n","Columbia University College of Physicians and
Surgeons"],"disclosure":""},{"name":"Albert L Siu, MD, MSPH","credentials":
["Professor\n","Department of Geriatrics and Pallative Medicine\n","Mount Sinai
School of Medicine"],"disclosure":""},{"name":"Marco L A Sivilotti, MD, MSc, FRCPC,
FACMT, FAACT","credentials":["Professor of Emergency Medicine and of Biomedical &
Molecular Sciences\n","Queen's University, Kingston Canada"],"disclosure":""},
{"name":"Roderick Skinner, PhD, MBChB, FRCPCH","credentials":["Consultant in
Paediatric and Adolescent Oncology/Bone Marrow Transplantation\n","Honorary
Professor of Childhood Cancer\n","Great North Children's Hospital\n","Northern
Institute of Cancer Research, Newcastle University"],"disclosure":""},
{"name":"Timothy W Smith, MD, PhD","credentials":["Associate Professor of
Medicine\n","Washington University School of Medicine"],"disclosure":""},
{"name":"Peter J Snyder, MD","credentials":["Editor-in-Chief —
Endocrinology\n","Section Editor — Pituitary Disease; Male Reproductive
Endocrinology\n","Professor of Medicine\n","University of Pennsylvania School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie
[Hypogonadism (Testosterone gel)]; Novo Nordisk [Growth hormone (Somatropin)];
Novartis [Cushing's (LCI699)]; Cortendo [Cushing's]. Consultant/Advisory Boards:
AbbVie [Hypogonadism (Testosterone gel)]; Novartis [Cushing's (LCI699)]; Pfizer
[Acromegaly (Pegvisomant)]; Watson [Testosterone (Testosterone gel)]."},
{"name":"Michael J Somers, MD","credentials":["Associate Professor of
Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Ramesh
Soundararajan, MD, FACP","credentials":["Clinical Assistant Professor of Internal
Medicine\n","Midwestern University College of Medicine"],"disclosure":""},
{"name":"Theodore I Steinman, MD","credentials":["Professor of Medicine\n","Harvard
Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Kadmon
[Tyrosine kinase inhibitor (Tesevitanib)]; Fibrogen [Hypoxia inducible factor
(Roxadustat)]. Consultant/Advisory Boards: Genzyme [Polycystic kidney disease]."},
{"name":"Richard H Sterns, MD","credentials":["Editor-in-Chief — Nephrology
\n","Section Editor — Fluid and Electrolytes\n","Professor Emeritus\n","University
of Rochester School of Medicine and Dentistry"],"disclosure":""},{"name":"Robert J
Stratta, MD","credentials":["Professor of Surgery, Director of
Transplantation\n","Wake Forest School of Medicine"],"disclosure":""},
{"name":"Jason R Stubbs, MD","credentials":["Associate Professor of
Medicine\n","Division of Nephrology & Hypertension\n","University of Kansas Medical
Center"],"disclosure":""},{"name":"José Such, MD, PhD","credentials":["Digestive
Disease Institute, Cleveland Clinic Abu Dhabi, UAE\n","Clinical Professor, Lerner
School of Medicine. Case Western Reserve University, OH, US"],"disclosure":""},
{"name":"Harold Szerlip, MD, FACP, FCCP, FASN, FNKF","credentials":["Director,
Nephrology Division, Baylor University Medical Center, Dallas\n","Program Director,
Nephrology Training Program, Baylor University Medical Center\n","Clinical
Professor of Medicine, Texas A&M College of Medicine\n","Adjunct
Professor of Medicine, Texas College of Osteopathic Medicine"],"disclosure":""},
{"name":"Matthew D Sztajnkrycer, MD, PhD","credentials":["Associate Professor of
Emergency Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"James
Tattersall, MD, MRCP","credentials":["Specialty Doctor in Renal Medicine\n","Leeds
Teaching Hospitals Trust"],"disclosure":""},{"name":"Eric N Taylor, MD,
MSc","credentials":["Associate Professor of Medicine\n","Tufts University School of
Medicine\n","Division of Nephrology and Transplantation\n","Maine Medical
Center"],"disclosure":"Consultant/Advisory Boards: Allena Pharmaceuticals [Kidney
stones and enteric hyperoxaluria (oxalate-degrading enzyme)]."},{"name":"Pablo
Tebas, MD","credentials":["Professor of Medicine\n","University of
Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Merck [HIV treatment
(Raltegravir)], Glaxo [Adjudication Committee (VZV vaccine)]."},{"name":"Stephen
Textor, MD","credentials":["Professor of Medicine\n","Division of Nephrology and
Hypertension\n","Mayo Clinic College of Medicine\n","Rochester,
Minnesota"],"disclosure":"Grant/Research/Clinical Trial Support: Stealth
Biopharmaceuticals [Mitochondrial protection (Bendavia)]."},{"name":"Ravi I
Thadhani, MD, MPH","credentials":["Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"George Thomas, MD, MPH, FACP,
FASN","credentials":["Director, Center for Blood Pressure Disorders, Cleveland
Clinic \n","Assistant Professor, Cleveland Clinic Lerner College of
Medicine"],"disclosure":""},{"name":"Garry S Tobin, MD","credentials":["Professor
of Medicine\n","Washington University School of Medicine"],"disclosure":"Speaker's
Bureau: Novo Nordisk [Diabetes (Insulin degludec, insulin detemir, NPH, insulin,
liraglutide)]; MannKind [Diabetes (Inhaled insulin)]."},{"name":"Ashita J Tolwani,
MD","credentials":["Professor of Medicine\n","University of Alabama at
Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Baxter; NxStage
[CRRT (CRRT training)]. Speaker's Bureau: Baxter [CRRT (CRRT devices)].
Consultant/Advisory Boards: Baxter [CRRT (CRRT devices)]. Patent Holder: Baxter
[CRRT (0.5 percent citrate anticoagulation for CRRT)]."},{"name":"Marcello Tonelli,
MD, SM, FRCPC","credentials":["Associate Vice President (Health Research),
University of Calgary\n","Senior Associate Dean (Clinical Research), Cumming School
of Medicine\n","Professor of Medicine, University of Calgary"],"disclosure":""},
{"name":"Vicente E Torres, MD","credentials":["Professor of Medicine\n","Mayo
Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support
[Otsuka (ADPKD)]."},{"name":"Raymond R Townsend, MD","credentials":["Professor of
Medicine\n","Perelman School of Medicine\n","University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: NIH Grants
(chronic kidney disease progression and CKD comorbidities). Consultant/Advisory
Boards: Medtronic [Hypertension (Renal denervation catheter)]. Other Financial
Interest: Travel support from NKF and ASN (hypertension, CKD)."},{"name":"Stephen J
Traub, MD","credentials":["Section Editor — Toxicology\n","Associate Professor of
Emergency Medicine\n","Mayo Medical School"],"disclosure":""},{"name":"Augusto
Vaglio, MD, PhD","credentials":["Nephrology\n","University Hospital, Parma,
Italy"],"disclosure":""},{"name":"Raymond Vanholder, MD, PhD","credentials":
["Professor Emeritus of Medicine\n","University Hospital, Ghent,
Belgium"],"disclosure":"Consultant/Advisory Boards: Debiotech [Hemodialyzers]."},
{"name":"John Varga, MD","credentials":["John and Nancy Hughes Professor of
Medicine\n","Northwestern University Feinberg School of
Medicine"],"disclosure":""},{"name":"Joseph Varon, MD, FACP, FCCP, FCCM,
FRSM","credentials":["Professor of Acute and Continuing Care, The University of
Texas Health Science Center at Houston\n","Clinical Professor of Medicine, The
University of Texas Medical Branch"],"disclosure":""},{"name":"Larissa I Velez,
MD","credentials":["Professor of Emergency Medicine\n","University of Texas
Southwestern Medical Center"],"disclosure":""},{"name":"John Vella, MD, FACP, FRCP,
FASN, FAST","credentials":["Associate Professor of Medicine\n","Tufts University
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas;
Bristol Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"Vijaya
Venkataraman, MD","credentials":["Consultant Nephrologist\n","Kidney Specialists
Inc. Columbus, OH"],"disclosure":""},{"name":"Sebastien Viatte, MD,
PhD","credentials":["Lecturer in Genetics\n","Arthritis Research UK Centre for
Genetics and Genomics\n","The University of Manchester, UK"],"disclosure":""},
{"name":"R Kasi Visweswaran, MD, DM, FRCP (Edin)","credentials":["Consultant in
Nephrology\n","Ananthapuri Hospital and Research Institute"],"disclosure":""},
{"name":"Demetrios V Vlahakos, MD","credentials":["Professor of Medicine and
Nephrology, Director, Renal Unit \n","Attikon University Hospital \n","Athens
University School of Medicine\n","National and Kapodistrian University of
Athens"],"disclosure":""},{"name":"Ron Wald, MDCM, MPH, FRCPC","credentials":
["Associate Professor, Department of Medicine \n","University of
Toronto"],"disclosure":""},{"name":"David Richard Walega, MD","credentials":
["Associate Professor\n","Northwestern University Feinberg School of
Medicine"],"disclosure":""},{"name":"Richard A Ward, PhD","credentials":["Professor
of Medicine\n","University of Louisville"],"disclosure":"Consultant/Advisory
Boards: Baxter Healthcare [Hemodialysis devices]."},{"name":"Alan Wasserstein,
MD","credentials":["Associate Professor of Medicine\n","University of Pennsylvania
School of Medicine"],"disclosure":""},{"name":"Terry Watnick, MD","credentials":
["Associate Professor of Medicine\n","University of Maryland School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka [Polycystic
kidney disease (Tolvaptan)]. Consultant/Advisory Board: PKD Foundation [Polycystic
kidney disease]. Patent Holder: Athena Diagnostics [Polycystic kidney disease (PKD
gene testing)]. Patent Holder (spouse): Athena Diagnostics [Polycystic kidney
disease (PKD gene testing)]."},{"name":"Virginia M Weaver, MD, MPH","credentials":
["Associate Professor of Environmental Health Sciences and Medicine\n","Associate
Faculty Member, Welch Center for Prevention, Epidemiology and Clinical Research
\n","Johns Hopkins Medical Institutions"],"disclosure":""},{"name":"Liza M Weavind,
MBBCh, FCCM, MMHC","credentials":["Professor of Anesthesiology and
Surgery\n","Vanderbilt University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Medtronic
[Capnostream]."},{"name":"Kathryn W Weibrecht, MD","credentials":["Emergency
Medicine Physician\n","Morton Hospital"],"disclosure":""},{"name":"Steven E
Weinberger, MD","credentials":["Adjunct Professor of Medicine\n","University of
Pennsylvania School of Medicine\n","Executive Vice President and CEO
Emeritus\n","American College of Physicians"],"disclosure":""},{"name":"Amy C
Weintrob, MD","credentials":["Associate Professor of Medicine\n","The George
Washington University and Veterans Affairs Medical Center"],"disclosure":""},
{"name":"Annika O Wernerson, MD, PhD","credentials":["Professor and Senior
Consultant in Pathology\n","Karolinska Institute, Sweden"],"disclosure":""},
{"name":"Jack FM Wetzels, MD, PhD","credentials":["Professor of
Nephrology\n","Radboud University Medical Center, Nijmegen, The
Netherlands"],"disclosure":""},{"name":"William L Whittier, MD","credentials":
["Associate Professor of Medicine\n","Rush University Medical
Center"],"disclosure":""},{"name":"Michael Wiederkehr, MD","credentials":
["Associate Professor, Department of Internal Medicine\n","Texas A&M Health Science
Center College of Medicine, Dallas"],"disclosure":""},{"name":"James F Winchester,
MD","credentials":["Professor of Medicine\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":""},{"name":"Karen Woo, MD","credentials":["Associate
Professor\n","UCLA Division of Vascular Surgery"],"disclosure":""},
{"name":"Christina M Wyatt, MD","credentials":["Associate Professor\n","Icahn
School of Medicine at Mount Sinai"],"disclosure":""},{"name":"Sri G Yarlagadda,
MD","credentials":["Associate Professor\n","University of Kansas Medical
Center"],"disclosure":""},{"name":"Melissa Y Yeung, MD, FRCPC","credentials":
["Instructor in Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Linwah Yip, MD","credentials":["Associate Professor of
Surgery\n","University of Pittsburgh School of Medicine"],"disclosure":""},
{"name":"William F Young, Jr, MD, MSc","credentials":["Professor of
Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Consultant/Advisory
Boards: Nihon Medi-Physics Co, Ltd [Primary aldosteronism (Novel PET-based adrenal
imaging)]."},{"name":"Alan S L Yu, MB, BChir","credentials":["Harry Statland and
Solon Summerfield Professor of Medicine\n","University of Kansas Medical
Center"],"disclosure":""},{"name":"Elaine W Yu, MD","credentials":["Assistant
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Mark L
Zeidel, MD","credentials":["Hermann L. Blumgart Professor of Medicine\n","Harvard
Medical School Physician-in-Chief and Chair\n","Department of Medicine Beth Israel
Deaconess Medical Center"],"disclosure":""},{"name":"Stéphane Zuily, MD, MPH,
PhD","credentials":["Associate Professor of Medicine, Nancy School of Medicine of
Lorraine University\n","Attending Physician, Vascular Medicine Division, Nancy
Academic Hospital"],"disclosure":""}]},{"name":"Peer Reviewers","contributors":
[{"name":"Nada Alachkar, MD","credentials":["Associate Professor of Medicine,
Division of Nephrology\n","The Johns Hopkins University School of
Medicine"],"disclosure":""},{"name":"Michael Allon, MD","credentials":["Professor
of Medicine\n","University
of Alabama at Birmingham"],"disclosure":"Consultant/Advisory Boards: Cormedix
[Dialysis catheter infections (nonantibiotic antimicrobial solution)]."},
{"name":"Anatole Besarab, MD","credentials":["Professor of Medicine\n","West
Virginia University School of Medicine"],"disclosure":"Consultant/Advisory Boards:
VascAlert [Vascular access for hemodialysis (Surveillance technique)]. Employment:
Fibrogen [Anemia of CKD (Roxadustat)] - No relevant conflict on topic."},
{"name":"Daniel G Bichet, MD","credentials":["Professor of Medicine\n","Universite
de Montreal"],"disclosure":"Grant/Research/Clinical Trial Support: Otsuka
Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry (Migalastat)],
Shire [Fabry (Replagal)], Sanofi Genzyme [Fabry (Fabrazyme)]. Speaker's Bureau:
Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry
(Migalastat)], Sanofi Genzyme [Fabry (Fabrazyme)]. Consultant/Advisory Boards:
Otsuka Pharmaceuticals [ADPKD (Tolvaptan)], Amicus Therapeutics [Fabry
(Migalastat)], Sanofi Genzyme [Fabry (Fabrazyme)]."},{"name":"Roy D Bloom,
MD","credentials":["Professor of Medicine\n","University of
Pennsylvania"],"disclosure":"Grant/Research/Clinical Trial Support: Veloxis
Pharmaceuticals [Immunosuppression (Tacrolimus)]; Care DX [Diagnostics (DNA blood
test)]. Consultant/Advisory Boards: Abbvie [Hepatitis C (Ombitasvir, paritaprevir,
ritonavir, plus dasabuvir)]; Merck [Hepatitis C (Elbasvir and grazoprevir)]; Care
Dx [Diagnostics (DNA blood test)]."},{"name":"John M Burkart, MD","credentials":
["Section Editor — Dialysis\n","Professor of Medicine/Nephrology\n","Wake Forest
University Medical Center"],"disclosure":"Employment: Health Systems Management."},
{"name":"Daniel C Cattran, MD","credentials":["Professor of Medicine\n","University
of Toronto, Canada"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech
[Membranous nephropathy, FSGS (Rituximab)]; Chemocentryx [FSGS].
Consultant/Advisory Boards: Mallinckrodt [Membranous nephropathy; focal and
segmental glomerulosclerosis (ACTH long-acting gel)]; Omerus [IgA]; Chemocentryx
[Vasculitis (C3G), FSGS]."},{"name":"Anil Chandraker, MD, FASN,
FRCP","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Antibody-
mediated rejection (Eculizumab)]. Consultant/Advisory Boards: T2 Biosystems; Dompé;
Veloxis [Immunosuppression (Tacrolimus)]."},{"name":"Marc E De Broe, MD,
PhD","credentials":["Emeritus Professor of Medicine\n","University of Antwerp,
Belgium"],"disclosure":""},{"name":"Bradley M Denker, MD","credentials":["Associate
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Joel D
Glickman, MD","credentials":["Professor of Clinical Medicine\n","University of
Pennsylvania School of Medicine"],"disclosure":""},{"name":"David S Goldfarb, MD,
FACP, FASN","credentials":["Professor of Medicine and Physiology\n","New York
University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Allena
[Nephrolithiasis (Allena 177)]; Retrophin (Cystinuria (Tiopronin)]. Patent Holder:
Ravine Group [Nephrolithiasis, cystinuria]."},{"name":"David JA Goldsmith, MA,
FRCP","credentials":["Visiting Professor\n","St. George's Hospital University
Medical School\n","GI Popescu School of Pharmacy and
Medicine"],"disclosure":"Speaker's Bureau: Amgen [CKD-MBD (Cinacalcet)]; Vifor
[CKD-MBD (Iron sucrose hydroxyoxide)]; Abbvie [CKD-MBD (Paricalcitol)]; Sanofi
[CKD-MBD (Sevelamer)]. Consultant/Advisory Board: Amgen [CKD-MBD (Cinacalcet)];
Vifor [CKD-MBD (Iron sucrose hydroxyoxide)]; Abbvie [CKD-MBD (Paricalcitol)];
Sanofi [CKD-MBD (Sevelamer)]."},{"name":"L Lee Hamm, MD","credentials":["Professor
of Medicine\n","Tulane University School of Medicine"],"disclosure":""},
{"name":"Karen Hardinger, PharmD, BCPS","credentials":["Clinical
Professor\n","University of Missouri-Kansas City"],"disclosure":""},{"name":"Jean L
Holley, MD, FACP","credentials":["Clinical Professor of Medicine\n","University of
Illinois, Urbana-Champaign"],"disclosure":""},{"name":"Keith Hruska,
MD","credentials":["Ira M Lang Professor of Medicine\n","Washington University
Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Celgene
[Renal fibrosis, CKD-MBD (Sotatercept)]. Consultant/Advisory Boards: Celgene; Vifor
[CKD-MBD (Sucroferric oxyhydroxide)]; Medikine."},{"name":"Chi-yuan Hsu, MD,
MSc","credentials":["Professor of Medicine\n","University of California, San
Francisco"],"disclosure":""},{"name":"Ramesh Khanna, MD, FACP","credentials":["Karl
D Nolph, MD Chair in Nephrology, Professor of Medicine\n","Vice Chair, Department
of Medicine\n","Director, Division of Nephrology\n","University of Missouri-
Columbia"],"disclosure":""},{"name":"Christina L Klein, MD","credentials":
["Transplant Nephrologist\n","Piedmont Transplant
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas [CMV (CMV
vaccine)]; Chimerix [CMV (Brincidofovir)]. Speaker's Bureau: Alexion [Atypical HUS
(Eculizumab)]. Consultant/Advisory Boards: Alexion [Atypical HUS (Eculizumab)]."},
{"name":"Edgar V Lerma, MD, FACP, FASN, FAHA","credentials":["SGIM Peer
Reviewer\n","Clinical Professor of Medicine\n","University of Illinois at Chicago
College of Medicine"],"disclosure":""},{"name":"Robert G Luke, MD","credentials":
["Taylor Professor of Medicine\n","University of Cincinnati Medical
Center"],"disclosure":""},{"name":"Orson Moe, MD","credentials":["Professor of
Medicine\n","UT Southwestern Medical Center at
Dallas"],"disclosure":"Consultant/Advisory Boards: Allena Pharmaceuticals
[Hyperoxaluria]; Ardelyx [Hyperphosphatemia]."},{"name":"David B Mount,
MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Ardea [Urate
transport (Lesinurad)]. Consultant/Advisory Boards: ZS Pharma [Potassium (ZS9)];
Relypsa [Potassium (Patiromer)]."},{"name":"Mark D Okusa, MD","credentials":
["Professor of Medicine\n","University of Virginia Health
System"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [AKI]; John Bower
Foundation [AKI]; Pfizer [Acute kidney injury (Recombinant alkaline phosphatase)].
Consultant/Advisory Boards: AM Pharma [AKI]. Patent Holder: B2 pharmaceutical
compositions having A2A adenosine receptor agonist activity; Methods and
compositions for treating inflammatory response. Equity Ownership/Stock Options:
Adenosine Therapeutics [AKI]."},{"name":"Mark Rosenberg, MD","credentials":
["Professor of Medicine\n","University of Minnesota Medical
School"],"disclosure":""},{"name":"John Vella, MD, FACP, FRCP, FASN,
FAST","credentials":["Associate Professor of Medicine\n","Tufts University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas;
Bristol Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"Anitha
Vijayan, MD","credentials":["Associate Professor of Medicine\n","Washington
University St Louis"],"disclosure":"Speaker's Bureau: NxSTage [CRRT, AKI
(Hemodialysis machine)]; Sanofi [Tumor lysis, AKI (Rasburicase)]."},
{"name":"Sushrut S Waikar, MD, MPH","credentials":["Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Genzyme [AKI]; Merck [AKI]; Otsuka [Hyponatremia]; Pfizer [AKI]; Satellite
[ESRD]; Biogen [Biomarkers]; Allena [CKD]. Consultant/Advisory Boards: Abbvie [CKD
(Endothelin antagonist)]; CVS Caremark [CKD]; Takeda [Hyponatremia (Tolvaptan,
febuxostat]; Harvard Clinical Research Institute [CKD (Canagliflozin)]; GSK [HIF
stabilizers, biomarkers]; Merck [Biomarkers]; Cerus [design of AKI trials]. Other
Financial Interest: GE Healthcare [ESRD (Gadodiamide)]; Fresenius [ESRD (Dialysis
concentrate)]; Pfizer [atorvastatin and diabetes]; Mercury exposure litigation."},
{"name":"Elaine Worcester, MD","credentials":["Professor of Medicine\n","University
of Chicago"],"disclosure":"Consultant/Advisory Boards: Allena [Product to increase
gut metabolism of oxalate]; OxThera [Product to increase gut metabolism of
oxalate]."},{"name":"Melissa Y Yeung, MD, FRCPC","credentials":["Instructor in
Medicine\n","Harvard Medical School"],"disclosure":""}]}]}

Vous aimerez peut-être aussi